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4Summary
This study was done to characterise the mechanism of action for the positive 
inotropic effect of prostaglandin F2a (PGF2a) in rat hearts. In Langendorff non­
working hearts perfused at a constant flow rate, PGF2a increased cardiac contractility 
in a dose dependent manner. The PGF2a analogue selective for FP receptors, 
cloprostenol, had a similar effect on cardiac contractility. Both drugs dilated 
coronary vessels, and with higher doses of PGF2a, coronary constriction preceded the 
dilator response. Heart rate was unchanged. Contractility of paced left atrial 
preparations also increased with PGF2a.
Single cell experiments were carried out to determine whether the mechanism of 
action of the PGF2a-induced positive inotropy depended on changes in intracellular 
Ca2+. Myocyte shortening was monitored by edge detection, while Ca2+ transients 
and intracellular pH were monitored with the fluorescent probes, fiira-2 and BCECF, 
respectively. At 3 pM, PGF2a increased the shortening amplitude of fura-2 loaded 
ventricular myocytes by 40%, but it did not increase the amplitude of intracellular 
Ca2+ transients. While diastolic cell length decreased with the same concentration of 
PGF2a, diastolic Ca2+ did not change. These two factors suggest that the sensitivity 
of the contractile filaments to Ca2+ were enhanced. Neither the duration of the Ca2+ 
transients, nor that of the contractions was affected.
However, a significant rise in intracellular pH of 0.08 pH units was detected in 
BCECF loaded myocytes with 3 juM PGF2ot. This alkalosis was abolished in the 
presence of HOE 694, a Na+-H+ exchange inhibitor, and attenuated by the protein 
kinase C (PKC) inhibitor, chelerythrine. Parallel experiments showed that the PGF2a- 
induced increase in myocyte shortening was also abolished by HOE 694, and 
attenuated by chelerythrine. Hence, the positive inotropic effect of PGF2a appears to 
be mediated by activation of PKC and the Na+-H+ exchanger, resulting in an 
intracellular alkalosis that sensitises the contractile filaments to Ca2+.
5Abbreviations
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1.1 Prostaglandin and the heart
Prostaglandin F2a (PGF2a) is one of the many endogenous modulators of cardiac 
contractility. It belongs to the prostanoid family of fatty acids, derived by 
cyclooxygenase mediated breakdown of arachidonic acid (diagram 1-1). Bergstrom 
& Sjovall first isolated PGF2a from sheep prostate glands in 1957. Since then, it has 
been found in many tissues, including those of non-mammalian vertebrates, 
invertebrates, fish and insects (Moore, 1985). In the heart, formation of PGF2ot 
occurs mainly in coronary vessels (Sivakoff et al., 1979), but cardiac myocytes also 
synthesise PGF2a (Ahumada et al., 1980).
Diagram 1-1. Pathway of PGF2a synthesis
Membrane phospholipids
phospholipase Aj or 
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prostacyclin thromboxane
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PGF2a is the most potent prostaglandin in increasing cardiac contractility 
(Vergroeson et al., 1967; Metsa-Ketela, 1981). This action of PGF2a may be 
important under conditions of ischaemia where contractility is compromised, as the 
release of this prostaglandin is significantly increased. Human hearts made 
temporarily ischaemic by rapid pacing are associated with almost a three-fold 
increase of PGF2a in the coronary sinus blood (Berger et al., 1977), whereas rat 
hearts with infarction and hypertrophy have six-fold more extractable PGF2a than 
control hearts (Lai et al., 1996).
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Besides affecting cardiac contractility, PGF2a also influences other cardiac functions. 
It constricts porcine and canine coronary vessels (Balwierczak, 1991; Rigel & Shetty, 
1997), and modulates cardiac rhythm. In rat hearts, low concentrations (pM-nM) of 
PGF2a are reported to be arrhythmic, while higher concentrations normalise the 
rhythm (Swift et al., 1978). Others have also shown that PGF2a modulates 
chemically-induced arrhythmias (Forster et al., 1973; Vapaatalo et al., 1978; Moffat 
et al., 1987). In a preliminary clinical trial, intravenous infusion of PGF2a abolished 
or reduced extrasystoles in five out of six patients (Mann et al., 1973). PGF2a also 
releases atrial natriuretic factor, ANF, from rat hearts and ventricular myocytes 
(Rayner et al., 1993; Lai et al., 1996), and causes ventricular hypertrophy (Adams et 
al., 1996; Lai et al., 1996). In fact, PGF2a produces about ten times more ANF than 
other hypertrophic agents such as phenylephrine and endothelin-1 (Lai et al., 1996). 
Additionally, PGF2a contributes to reperfusion injury of ischaemic rat hearts 
(Karmazyn, 1986).
In view of PGF2a's complex cardiac actions and its enhanced release during 
myocardial ischaemia, the primary aim of this study is to determine the mechanism 
mediating the PGF2a-induced increase in cardiac contractility. If this could be 
elucidated, then it would hopefully add to our understanding of how cardiac 
contractility is normally controlled, and how this mechanism could contribute 
towards PGF2a’s other cardiac actions.
An increase in cardiac contractility in the absence of preload and afterload is termed 
'positive inotropic1. It is defined as 'an increase in work performed during the cardiac 
cycle not caused by a change in initial fibre length' (Katz, 1992). The positive 
inotropic action of PGF2a may be achieved by either an increase in intracellular Ca2+ 
or an increase in the sensitivity of the contractile filaments to Ca2+. The basis 
underlying cardiac contraction and the possible mechanisms of the positive inotropic 
action of PGF2a are considered in the following sections.
Introduction - 14
1.2 Cardiac action potentials
Cardiac contractility is dependent on action potentials that are generated by electrical 
activity normally derived from the sinus node, and propagated along conductive 
tissues. The sarcolemmal membrane potential is normally maintained by the Na+/K+ 
ATPase and the inward rectifier K+ current at around -80 mV. During an action 
potential (reviewed by Ten Eick et al., 1992), depolarisation beyond about -70 mV 
activates a large, rapidly inactivating Na+ current (INa) that manifests in the upstroke 
of the action potential (diagram 1-2). This Na+ influx depolarises the cells and 
activates voltage dependent L-type Ca2+ channels. Following the peak of the 
upstroke, rapid repolarisation occurs primarily from inactivation of this Na+ current 
and activation of a transient outward current carried by K* and Cf (Ito). The 
subsequent plateau phase arises from a balance between the inward L-type Ca2+ 
current (Ica) and plateau-activated outward K+ current (Ikpi)- Ca2+ entry through 
Na+-Ca2+ exchange (lNa-ca) may also occur. It is the entry of Ca2+ occurring during 
the action potential plateau that activates cardiac contraction. Inactivation of the 
Ca2+ current and repolarisation by outward K+ currents (delayed rectifier IK, and 
inwardly rectified IKi) then return membrane potential to the resting level.
Action potentials vary in their shape depending on species and on their location in the 
myocardium. For example, the transient outward K+ current is more pronounced in 
atrial than in ventricular myocytes. Hence, the plateau of the action potential is much 
less pronounced in atrial myocytes (Berne & Levy, 1992).
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Diagram 1-2. An action potential recorded from an isolated feline ventricular 
myocyte using the patch electrode. Inward currents are depicted by arrows directed 
"into the action potential" and outward currents directed by arrows "out of the action 
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1.3 The im portance of C a2* in cardiac contractility
Contraction of a single cardiac myocyte is dependent on the force generated between 
the cytosolic thick filamentous protein, myosin, and thin filamentous protein, actin, 
during the 'cross-bridge' cycle (see diagram 1-3 below). Before this cycle begins, the 
ATP-bound myosin is unattached to actin. Interaction between actin and myosin is 
hindered by the troponin complex and tropomyosin, both of which also make up the 
thin filaments. Troponin T attaches the troponin complex to actin and tropomyosin, 
troponin I inhibits the actin-myosin interaction, while troponin C binds Ca2+.
It is the binding of Ca2+ to troponin C in the presence of ATP and Mg2+ that triggers 
the cross-bridge cycle. Conformation of the troponin complex then changes so that 
tropomyosin shifts out of the way and interaction of actin to myosin occurs. The 
globular heads of myosin attach actin, flex, and hydrolyse ATP. Repetition of this 
cross-bridge cycle at many points along each filament (myofibrillar ATPase activity) 
produces the force that causes sliding of the filaments past one another, which results 
in myocyte contraction. Relaxation follows when Ca2+ leaves troponin C, and the 
myosin heads release actin.
Diagram 1-3. Diagram depicting the ultrastructure of thin and thick myofilaments of 
cardiac muscle. Bold P indicates a site of covalent phosphorylation. The proteins 
that make up the troponin complex are troponin T, the tropomyosin binding unit; 
troponin I, the inhibitory unit; and troponin C, the Ca2+ binding unit. Taken from 
Solaro, 1993.
Tropomyosin
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Diagram 1-4 (1-7) shows the main factors involved in regulating cell Ca2+. During an 
action potential (1), Ca2+ influx occurs through L-type Ca2+ channels and perhaps the 
Na+/Ca2+ exchanger (2). This amount of Ca2+ is generally insufficient to activate the 
contractile proteins in mammalian cardiac muscle, but it triggers more Ca2+ release 
from the sarcoplasmic reticulum via the ryanodine receptors, a process known as 
'Ca2+-induced Ca2+ release' (3). This cytosolic Ca2+ then binds to intracellular sites 
that include troponin C, calmodulin and the sarcoplasmic reticulum. Contraction is 
initiated when Ca2+ binds to troponin C (4). Inactivation of the Ca2+ current and 
repolarisation by outward K+ currents (delayed rectifier, and inwardly rectified K+ 
currents) inhibit further Ca2+ entry. For relaxation to occur, Ca2+ leaves troponin C, 
and the free cytosolic Ca2+ concentration is then reduced by several mechanisms. 
Active sarcoplasmic reticulum Ca2+ uptake through the Ca2+ ATPase replenishes 
sarcoplasmic reticulum Ca2+ stores (5). Ca2+ is also extruded through both the 
sarcolemmal Na+-Ca2+ exchanger and the Ca2+ ATPase (6), and when Ca2+ overload 
occurs, the mitochondria also becomes a sink for Ca2+ (7).
Diagram 1-4. Ion fluxes in cardiac muscle. See text above for details. Note that K+ 
efflux occurs through several types of K+ channels.
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1.4 Regulation of cardiac contractility at the cellular level
Manipulations that either increase cytosolic Ca2+ or increase Ca2+ sensitivity of the 
contractile proteins will increase contractility. These processes are either modulated 
directly at the sites discussed below or indirectly at the receptor and second 
messenger level.
a) Processes increasing cytosolic Ca2+
An increased Ca2+ level can be achieved by several ways. Firstly, increased L-type 
Ca2+ channel activity will increase Ca2+ entry into the cell. Also, reduced K+ efflux 
during an action potential will decrease the membrane potential and prolong Ca2+ 
influx. Secondly, increased Ca2+ influx, or reduced Ca2+ efflux can occur by 
manipulation of the Na+/Ca2+ exchanger. Reduction of the Na+ gradient across the 
cell membrane occurring during Na+/K+ ATPase inhibition, and possibly Na+ channel 
or Na+/H+ exchanger activation, will also affect Na+/Ca2+ exchanger activity. 
Reduced Ca2+ extrusion by the sarcolemmal Ca2+ ATPase can also increase cytosolic 
Ca2+. Thirdly, increasing sarcoplasmic reticulum Ca2+ uptake, therefore increasing 
Ca2+ loading and release, will increase cell Ca2+. Phosphorylation of phospholamban, 
a protein that inhibits the sarcoplasmic reticulum Ca2+ ATPase, enhances Ca2+ 
loading. Inhibition of the phosphatase regulating phospholamban will also increase 
Ca2+ stores. Additionally, Ca2+ release from the sarcoplasmic reticulum can also be 
modulated at the site of the ryanodine receptor, and more controversially through the 
IP3 receptor.
b) Processes increasing Ca2+ sensitivity of the myofilaments
Ca2+ sensitivity of the contractile filaments can be regulated in the following ways. 
Firstly, the affinity of troponin C for Ca2+ can be enhanced, for example, by direct 
phosphorylation of troponin C, conformational changes of troponin C, or by 
cytosolic alkalosis. Secondly, Ca2+ sensitivity may be increased by altering 
myofibrillar ATPase activity, either by altering the number of cross-bridges or the 
force produced per cross-bridge. This will change the maximum Ca2+ activated 
force.
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Both increased Ca2+ binding to troponin C and change in maximum Ca2+ activated 
force can be theoretically differentiated (Lee & Allen, 1993), as shown in diagram 1-5 
below.
In the top figure of diagram 1-5, the right-hand curve shows the Ca2+-force relation 
under control conditions, while the left-hand curve shows the effect of increasing the 
Ca2+ occupancy of troponin C at any given cell Ca2+. This parallel leftward shift of 
the whole Ca2+-force relation results in a greater generation of force at a given cell 
Ca2+ (illustrated by the dotted lines), and a lowered threshold Ca2+ for force 
generation. Relaxation of tension will therefore be slower under this condition 
because the off-rate of Ca2+ binding to troponin C is reduced.
The bottom figure shows the effects of changing maximum Ca2+ activated force. The 
Ca2+ force relation under control conditions is illustrated by the lower curve, while 
the upper curve shows the effects of increasing the maximum Ca2+ activated force. 
Not only is the maximum force increased, but the force response also saturates at the 
same cell Ca2+. Additionally, the threshold for cell Ca2+ for force generation does not 
change.
2+Diagram 1-5. Schematic representations of the effects of a pure change in Ca 
sensitivity, for example, due to alteration of the Ca2+ affinity of troponin C (above) 
and a change in maximum Ca2+-activated force (below). See text above for further 
discussion. Taken from Lee & Allen, 1993.
FO R CE <%)
Change in Ca2* affinity 
of troponin C
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An example by which cardiac contractility can be modulated is by stimulation of the 
pi-adrenergic receptor by isoprenaline or noradrenaline (Endoh & Blinks, 1988; 
Solaro, 1993). Activation of the pi-adrenergic receptor results in cAMP-mediated 
protein kinase A stimulation. Protein kinase A phosphorylates L-type Ca2+ channels 
and phospholamban, and increases Ca2+ influx and sarcoplasmic reticulum Ca2+ 
loading respectively. This results in more Ca2+ being available for contraction. 
Additionally, protein kinase A phosphorylates troponin I and desensitises the 
contractile filaments to Ca2+, and this, coupled with the enhanced Ca2+ loading of 
sarcoplasmic reticulum, shortens the duration of contraction.
Both the possibilities of increased cytosolic Ca2+ and increased Ca2+ sensitivity of the 
contractile proteins were considered in this thesis when studying the actions of PGF2a 
in isolated perfused rat hearts, isolated atria and single ventricular myocytes.
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1.5 The models and species used in this thesis
The actions of PGF2a were first studied in isolated Langendorff perfused, non­
working rat hearts. This model is not influenced by preload, afterload, circulating 
hormones or the peripheral nervous system. Besides contractility, several other 
parameters can also be measured in the whole heart, including heart rate, and 
coronary perfusion pressure, the latter of which gives a measure of coronary tone. 
However, the presence of fibrous tissue, the geometrical arrangement of muscle 
fibres and changes in coronary perfusion pressure ('garden hose effect') can affect 
cardiac contractility.
To overcome the influence of coronary perfusion pressure, the positive inotropic 
effect of PGF2<x was also studied in rat isolated atria and in single ventricular 
myocytes. The single myocyte model has an advantage over the atrial preparation as 
it is not influenced by substances released by other non-myocyte cells, or by 
hormones such as noradrenaline released from nerves during electrical stimulation. 
Additionally, single myocytes do not have diffusion barriers. Because of the 
technical difficulty in stretching intact myocytes, myocyte shortening, as opposed to 
force, is taken as a measure of contractility. Myocyte shortening can be recorded 
either by methods employing light diffraction techniques, or by direct monitoring of 
microscopic myocyte images (reviewed by Delbridge & Roos, 1997). In this thesis, 
the latter method was used.
The rat was used in the experiments in this thesis because besides being relatively 
cheap, previous studies have shown that it responds best to PGF2a compared to other 
species. In fact, the positive inotropic action of PGF2a was first observed by 
Vergroeson and his colleagues (1967) in the isolated perfused heart of this species. 
Subsequent experiments demonstrating this effect with PGF2a in rat and guinea-pig 
hearts followed (see following pages, table I-la,b). Dog, rabbit and human hearts, 
however, respond inconsistently to PGF2a (table I-lc,d,h), while cat, chick and toad 
hearts do not show the positive inotropy (table I-le,f,g). These species dependent 
responses may reflect the differences in abundance of the receptor or the signal 
transduction mechanisms involved in mediating the inotropic effect.
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Table 1-1. Species dependent inotropic effects of PGF2a: 
a) RAT
Authors Preparation [PGF2«] inotropic response.










28 nM & 
280 nM
positive, increased rate of 
developed tension and 
rate of relaxation, 




Vapaatalo et al., 
1978
isolated right atria 10 pM positive, under conditions 
of either hypopotassemia 
or hyperpotassemia




0.1 p M &  
10 pM




isolated right atria 50 pM positive, PGF2a > PGE2 > 
PGEi~PGI, biphasic, 
max. effect after 2.5 min, 
duration of contraction 
initially increased, no 
action on cAMP, atrial 
45Ca2+ accumulated




28 pM -  280 nM positive, sarcolemmal 
Na+/K+ ATPase, but not 
Ca2+ ATPase or Mg2+ 
ATPase, inhibited




1 pM  to 100 pM negative
Otani et al., 1988 isolated papillary 
muscle
1 nM -  1 pM 
(EC50 = 30 nM)
positive, phosphoinositide 
hydrolysis detected
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Table 1-1. Species dependent inotropic effects of PGF2a: 
b) GUINEA-PIG
Authors Preparation [PGF2«]/Dose Inotropic effect?
Sabatini -  Smith, 
1970









Nutter & Ratts, 
1973















0.21 pM to 
21 pM 




Rettkowski et al., 
1978a
isolated right atria 28 pM positive, in the presence 
of verapamil
Rettkowski et al., 
1978b
isolated atria 28 nM to 2.8 
pM
increased cardiac work
Taube et al., 1978 isolated perfused 
heart
10 pg bolus negative, in parallel with 
reduced coronary flow
Mentz eta l., 1978 isolated atria 2.8 pM positive, with a higher % 
increase in contractility at 
lower extracellular Ca2+
Otani et al., 1986 isolated right atria 0 .1 - 1 0  pM positive, unaffected by 
verapamil but inhibited by 
procaine or TMB-8. 
Unaffected by increased 
extracellular Ca2+
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Table 1-1. Species dependent inotropic effects of PGF2tt: 
c) DOG
Authors p [PGF2a]/D ose Inotropic response?







































0.5 - 12.5 pg
positive
Bloor et al., 1973 anaesthetised
animals
intravenous, 
via left atrium, 
intracoronary, 
various doses 0.1 
- 3 pg/kg/min, or 
0 . 0 1 - 1  pg/kg
none
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Table 1 -1 . Species dependent inotropic effects of PGF2a: 
d) RABBIT
Authors Preparation [PGF2a] / dose Inotropic response?
Nutter & Ratts, 
1973
isolated left atria 28 pM none




5.2 -  8.4 pmoles 
bolus
positive
Table 1 -1 . Species dependent inotropic effects of PGF2ct:
e) CAT
Authors Preparation* [PGF^l Inotropic effect?




Ogletree et al., isolated perfused 2.8 pM none
1975 hearts,
papillary muscles 280 pM - none
2.8 pM
Table 1-1. Species dependent inotropic effects of PGF2a:
f) CHICK
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Table 1 -1 . Species dependent inotropic effects of PGF2a: 
g) TOAD
Authors Preparation [PGF2a] Inotropic response?
Nutter & Ratts, 
1973
ventricular strips 28 pM negative
Table 1-1. Species dependent inotropic effects of PGF2a:
h) HUMAN
Authors Subject PGF2«dose Inotropic response?




none, PGF2a not detected 
in venous blood












2 5 -  100 pg/min
negative?, total 
electromechanical systole, 
preejection period and 




PGF2(x is an agonist for the FP prostaglandin receptor, which is coupled to Gq-protein 
activated phosphoinositide breakdown (reviewed in Coleman et a l , 1994). Since 
DNA and mRNA encoding the FP receptor are present in rat heart tissue (Lake et 
a l , 1994; Adams et a l , 1996), the positive inotropic effect of PGF2a may be receptor 
mediated. Moreover, FP receptor mRNA is expressed in neonatal rat hearts 
primarily in ventricular myocytes and secondarily in smooth muscle (Adams et a l , 
1996), suggesting that PGF2a has a regulatory function in the myocardium. While 
the cloned FP receptor from the rat corpus luteum consists of 366 amino-acids, the 
cloned FP receptor from bovine corpus luteum and human uterus consist of 362 and 
359 amino-acids respectively (Lake et a l , 1994; Sakamoto et a l , 1994; Abramovitz 
et a l , 1994). Since additional transcripts of lower size to that of the receptor were 
detected, either subtypes of the FP receptor exist in rat heart (Lake et a l , 1994), or 
the transcript encodes for a negative regulatory protein termed prostaglandin F2a 
receptor associated protein, FPRP (Orlicky, 1996).
While PGF2a is a potent ligand for the FP receptor, it is not selective since it can also 
bind the PGE selective EP, and thromboxane selective TP receptors. Conversely, the 
FP receptor can also be activated by PGD2. Nevertheless, the availability of the 
highly selective FP receptor agonist, cloprostenol, allows FP receptor activation to 
be studied in the absence of potent FP receptor antagonists (Coleman et a l , 1994). 
Thus, in this thesis, initial experiments in the isolated perfused rat heart compares the 
positive inotropic effect induced by PGF2a and cloprostenol. The chemical structures 
of PGF2ot and cloprostenol are shown in diagram 1-6 below.
Diagram 1-6. Chemical structures of PGF2a and cloprostenol
HO HO
\ / X — / X X sVCOOH
hc5 1 h  d o /fV c'OH OH u
p g f 2(X cloprostenol
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1.7 PGForv signal transduction mechanisms
Although the signal transduction mechanisms activated by PGF2a have been studied 
in other cell types, there is little information regarding this in cardiac muscle (diagram 
1-7). The following sections will discuss the possible second messenger systems 
activated by PGF2a and also its potential ways for Ca2+ modulation and Ca2+ 
sensitisation of the myofilaments.
a) cAMP
Many positive inotropic agents increase cardiac contractility by increasing cytosolic 
levels of cAMP. Agents that activate the pi-adrenergic receptor such as isoprenaline 
and noradrenaline, and agents that stimulate adenylate cyclase such as forskolin, and 
cAMP phosphodiesterase inhibitors such as milrinone, do increase cAMP and 
enhance cardiac contractility. cAMP activates protein kinase A, which 
phosphorylates L-type Ca2+ channels and phospholamban. This potentiates Ca2+ 
influx, and sarcoplasmic reticulum Ca2+ uptake and release, respectively. However, 
cAMP does not seem to be involved in the positive inotropic effect of PGF2a, as 
Otani et al. (1988) and Metsa-Ketela (1981) both showed that cAMP levels were 
unchanged in rat hearts treated with PGF2a.
b) Mitogen activated protein kinase (MAPK) cascade
The MAPK cascade is an important signalling pathway for cell proliferation. 
However, it may also regulate muscle contractility. In rat uterine muscle, Ohmichi et 
al. (1997) showed that rapid activation of this cascade is partially responsible for the 
PGF2a-induced contraction, as a MAPK kinase inhibitor reduced the contractile 
effect. Since PGF2a also activates members of this cascade in NIH-3T3 cells 
(Watanabe et al., 1995) and osteoblastic MC3T3-E1 cells (Hakeda et al., 1997), 
there is a possibility that activation of this cascade plays a role in the positive 
inotropy of PGF2ot in the heart.
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Diagram 1-7. PGF2a signal transduction mechanisms
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Legend
The legend indicates where the receptor/second 
messenger was found, the concentration and 
period of contact with PGF2a> references, and 
other relevant details.
Experiments were done in cardiac tissue where 
highlighted red in the diagram.
production or direct activation 
 >. indirect/(direct?) activation
1. rat pregnant corpus, Orlicky, 1996.
2. NIH-3T3 cells, 1- 3 min with 1 pM PGF^, 
independent of extracellular Ca2+,
Ca2+/calmodulin kinase, dependent on Ca2+, 
Watanabe etal., 1994.
3. NIH-3T3 cells, 3 min with 1 pM PGF2a. 
Watanabe et al., 1995.
4. NEH-3T3 cells, peak at 3 min with 1 |±M PGF2a, 
HDso= 10 nM, independent of extracellular Ca2+, 
Ca27calmoduIin kinase, Watanabe et al., 1995.
5. NIH-3T3 cells, peaked at 3 min with 1 pM 
PGF2a, HDso = 10 nM, partially dependent on 
Ca2+. Dose dependence of MAPK & MAPKK 
activation similar to that of phospholipase C 
activation, Watanabe et al., 1995.
6. Balb/c/3T3 fibroblast cells, breakdown within I 
min, Fukami & Takenawa, 1989.
7. Balb/c/3T3 fibroblast cells, breakdown within 7 
min, Fukami & Takenawa, 1989.
8. Balb/c/3T3 fibroblast cells, max at 30 s, 
decreased to control level within 2 min, Fukami & 
Takenawa, 1989.
9. MC3T3-E1 osteoblast-like cells, 2 - 4  min with 
1 pM PGF2a, dependent on Ca2+, independent of 
PKC, partially responsible for 2nd DAG phase 
after 2 min from breakdown of other lipids, 
Sugiyama et al., 1994.
10. MC3T3-E1 osteoblast-like cells, biphasic, 
Sugiyama et al., 1994.
11. Balb/c/3T3 fibroblast cells, biphasic, 1st phase 
30s, 2nd phase up to 7 min, Fukami & Takenawa, 
1989.
12. neonatal myocytes, 30 min with 1 pM PGFta, 
Lai et al., 1996.
13. neonatal myocytes, 48 hr with 1 pM PGF2a, 
Lai et al., 1996.
14. neonatal myocytes, 48 hr, 1 nM - 1 pM PGF2a, 
adult myocytes, 72 hr, 1 nM-1 jUM PGF2a, Lai et 
al., 1996.
15. MC3T3-E1 osteoblast-like cells, Sugiyama et 
al., 1994.
16. neonatal rat ventricular myocytes > vascular 
smooth muscle cells »  cardiac fibroblast-like 
cells, Adams et al., 1996.
17. neonatal rat ventricular myocytes, 36 hrs, 0.1 
pM PGF2a, Adams et al., 1996.
18. rat mesangial cells, lypM PGF2a, Mene et al., 
1991.
19. neonatal mouse clonal osteoblast-like cell line, 
MOB 3-4, 0.05 - 5 pg/ml PGF2a, Kawase et al., 
1991.
20. neonatal mouse clonal osteoblast-like cell line 
MOB 3-4, »  50 ng/ml PGF2a, Kawase et al., 
1991.
21. rat papillary muscles, peaked at 30 s with 1 
ytfM PGFza, Otani et al., 1988.
22. osteoblastic MC3T3-E1 cells, occurs within 5 
min, max at 0.3 pM PGF2a, Hakeda et al., 1997.
23. osteoblastic MC3T3-E1 cells, Hakeda et al., 
1997.
24. osteoblastic MC3T3-E1 cells, Hakeda et al., 
1997.
25. osteoblastic MC3T3-E1 cells, max at 2min 
with 1 pM PGF20. PKC dependent, Hakeda et al., 
1997.
26. osteoblastic MC3T3-E1 cells, 1 pM PGF2a. 10 
min, 37°C, Kato etal., 1997.
27. rat puerperal uterine cells, increased activity 
after 5 min with 1 pM PGF2a, Ohmichi et al., 
1997.
28. rat puerperal uterine cells, 5 min with 
1 pM PGF2a . . Ohmichi et al., 1997.
29. rat puerperal uterine cells, 5 min with 1 pM 
PGF2a , , Ohmichi et al., 1997.
30. rat puerperal uterine cells, occurs within 1 min 
with 1 pM PGF2a, maximum by 30 min, Ohmichi 
eta l., 1997.
31. rat puerperal uterine cells, 5 min with 1 pM 
PGF20, Ohmichi et al., 1997.
32. rabbit jugular vein, Chen etal., 1995.
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c) Phosphoinositide cascade
PGF2a activates phospholipase C mediated phosphatidylinositol 4,5-bisphosphate 
( P I P 2 )  breakdown in a fibroblast cell line (Fukami & Takenawa, 1989). While 
increased levels of the breakdown product, inositol 1,4,5-trisphosphate ( I P 3 ) ,  are 
detected in rat papillary muscle following PGF2a treatment (Otani et al., 1988), 
sustained activation of the other breakdown product, 1 ,2 -diacylglycerol, occurs in 
osteoblast-like and fibroblast cell lines (Sugiyama et al., 1994; Fukami & Takenawa, 
1989). Breakdown of other lipids such as phosphatidylcholine by phospholipase D 
may also contribute to this sustained diacylglycerol signal (Sugiyama et al., 1994).
Both the PIP2 breakdown products IP3 and diacylglycerol may increase cardiac 
contractility by different mechanisms (De Jonge et al., 1995). Although IP3-induced 
release of Ca2+ from Ca2+ stores has been shown in many cell types (Berridge & 
Irvine, 1984), this may not occur in cardiac cells. Photorelease of 'caged IP3' causes 
a small, inconsistent release of sarcoplasmic reticulum Ca2+ in saponin skinned 
ventricular trabeculae from rats (Kentish et al., 1990). IP3 does not release Ca2+ in 
rat ventricular myocytes or from canine cardiac sarcoplasmic reticulum vesicles 
(Movsesian et al., 1985). Additionally, receptors for IP3 in rat ventricular myocytes 
are not immunolocalised at the sarcoplasmic reticulum, but at the intercalated discs 
(Kijima et al., 1993). In contrast, diacylglycerol increases cardiac contractility by 
activation of protein kinase C (Pi et al., 1997).
d) Protein kinase C (PKC)
PKC is composed of a family of serine/threonine kinases that vary in their cofactor 
requirements for enzymatic activity, tissue distribution and subcellular localisation 
(Nishizuka, 1995; Hofmann, 1997). The inotropic effects of PKC are controversial, 
as PKC is claimed to increase or decrease contractility, either by modulating Ca2+ 
levels (Macleod & Harding, 1991; Capogrossi et al., 1990; Karmazyn et al., 1990), 
or by phosphorylating contractile proteins (Clement et al., 1992; Jideama et al., 
1996). Furthermore, eleven isozymes of protein kinase C have been identified, and 
preferential activation of an isozyme may influence contractility. The current view is 
that in adult ventricular myocytes, PKC-e is abundantly expressed (Bogoyevitch et
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al, 1993; Rybin & Steinberg, 1994), PKC-8 and perhaps - a  and-£ are detectable 
(Puceat et a l ,  1994; Rybin et al., 1997) but PKC-p and -y are not detectable (Rybin 
& Steinberg, 1994). The phosphorylation of myosin light chain by PKC has been 
implicated in its ability to sensitise cardiac myofilaments to Ca2+ (Clement et al., 
1992; Venema et al., 1993), but PKC-a, -8 and -e can decrease the sensitivity of 
actomyosin MgATPase by selective phosphorylation of troponin I and T. In 
contrast, PKC-£ phosphorylation of troponin T results in a slight increase in Ca2+ 
sensitivity without affecting the maximal activity of MgATPase (Jideama et al.,
1996).
The modulation of cardiac membrane targets by PKC is controversial and is reviewed 
by Puceat and Vassort (1996). The potential phosphorylation sites and actions of 
PKC are listed in table 1-2 below.
Table 1-2. Modulation of cardiac membrane targets by PKC
Target Action
15kDa protein named 
phospholemman
may or may not stimulate chloride conductance
phospholamban increase or decrease sarcoplasmic reticulum Ca2+ 
uptake
K+ channels:
voltage activated outward, 
delayed rectifier
prolongation or shortening of the action potential, 
affecting the duration of Ca2+ influx
(Sna-rHl) Na+ channel decreases Na+ current
Ca2+ channel transient increase in L-type Ca2+ current, 
inhibition of T-type Ca2+ current
Na+/H+ exchanger may or may not activate
Na+/Ca2+ exchanger may activate
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1.8 Possibility of cytosolic Ca2+ level regulation bv PGF?™
As discussed from the previous section, PGF2(X may increase intracellular Ca2+ via 
PKC or by I P 3 .  However, evidence for the role of Ca2+ in the PGF2a-induced 
positive inotropic effect is unclear.
PGF2(x is reported to accumulate 45Ca2+ in the rat heart (Metsa-Ketela, 1981) but not 
in the guinea-pig heart (Sabatini-Smith, 1970). If Ca2+ accumulation does occur with 
PGF2a, a source of Ca2+ entry may be the L-type Ca2+ channel. Otani et al. (1988) 
reported that PGF2a initiated contractions of 25 mM K+ depolarised, electrically 
paced rat papillary muscles, and that this effect was inhibited with the L-type Ca2+ 
channel blocker, nifedipine. Furthermore, action potential duration is prolonged in 
rat and guinea-pig papillary muscles treated with PGF2oc (Forster et al., 1974; January 
& Schottelius, 1974). One of the possible explanations for this effect is an increase 
in the L-type Ca2+ current, but this effect can also be interpreted either as a reduction 
in the K+ and Cl' currents, or an increase in the Na+ current. However, the Ca2+ 
channel blocker, verapamil, does not inhibit the PGF2orinduced increase in guinea-pig 
cardiac contractility (Otani et al., 1986).
PGF2a also increases Ca2+ uptake of guinea-pig fragmented sarcoplasmic reticulum 
membranes (Sabatini-Smith, 1970), while apparent inhibition of sarcoplasmic 
reticulum Ca2+ release in guinea-pig atria reduces the PGF2ot-induced positive 
inotropy (Otani et al., 1986). Additionally, increased Ca2+ influx may occur by 
Na+/Ca2+ exchange. Since PGF2a inhibits the Na+/K+ ATPase activity of fragmented 
rat sarcolemmal membranes (Karmazyn et al., 1981), this would in turn affect 
Na+/Ca2+ exchange.
Thus, in this thesis, to find out if PGF2(X increases Ca2+ availability to the contractile 
filaments, I monitored Ca2+ transients by fluorimetric methods in electrically 
stimulated, fura-2 loaded rat ventricular myocytes. Additionally, Dr. Katherine 
Reeves monitored L-type Ca2+ currents in patch clamp experiments in the same 
laboratory.
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1.9 Possibility of cytosolic pH regulation by PGF?„
PKC (Kandasamy et al., 1995), members of the MAPK cascade (Noel & 
Pouyssegur, 1995) and Ca2+-calmodulin kinase (Fliegel et al., 1992; Le Prigent et al,
1997) modulate intracellular pH by activating the sarcolemmal Na+/H+ exchanger in 
many cell types. The Na+/H+ exchanger extrudes one H+ in return for one Na+, and is 
driven by the Na+ gradient generated by the Na+/K+ ATPase. It is an important 
mechanism for modulating internal pH, alongside the Na+/HC03‘ symport and the 
Na+ dependent HCCV/Cl" antiport. Additionally, the Na+/H+ exchanger modulates 
cell growth, volume and salt balance (Noel & Pouyssegur, 1995).
PGF2a stimulates the Na+/H+ exchanger in kidney and osteoblast cell lines (Kawase et 
al., 1991; Mene et al., 1991). If such an effect also occurs in the PGF2a-treated 
heart, then the cytosolic alkalosis produced may be important in the positive 
inotropy. PKC activators such as phenylephrine and endothelin-1 are thought to 
increase cardiac contractility at least partly by activating the Na+/H+ exchanger and 
increasing cytosolic pH (Kramer et al., 1991; Puceat et al., 1992; Khandoudi et al., 
1994). This is because cytosolic alkalosis sensitises the contractile filaments to Ca2+ 
(Fabiato & Fabiato, 1978).
Cytosolic pH of myocytes can be measured by means of pH selective microelectrodes 
or by pH sensitive dyes (Frohlich & Wallert, 1995). In this thesis, the pH sensitive 
dye, BCECF, was used because of the availability of the instruments. Additionally, 
the involvement of the Na+/H+ exchanger in the positive inotropic effect of PGF2a 
was tested by using the exchanger inhibitor, HOE 694 (Scholz et a l,  1993; diagram 
1-8). HOE 694 is more selective for the Na+/H+ exchanger compared to the older 
generation amiloride derivatives. It also preferentially inhibits NHE-1 (which stands 
for Na+/H+ isoform 1), which is predominant in the heart, over the other isoforms 
NHE-2, NHE-3 and NHE-4 (Loh et a l, 1996).
In addition, the potent and selective inhibitor of PKC, chelerythrine, was used in this 
thesis to investigate the role of PKC in mediating the effects of PGF2a. Chelerythrine 
is an alkaloid that inhibits PKC with an I C 5 0  of 0.66 |iM (Herbert et al., 1990;
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diagram 1-8). It interacts with the catalytic domain of PKC at a site different from 
that of phorbol esters. Unlike the other classical PKC inhibitors such as 
staurosporine and H7 that inhibit other protein kinases, very high concentrations of 
chelerythrine are needed to inhibit protein kinase A, tyrosine kinase or 
Ca2+/calmodulin protein kinase (Herbert et a l , 1990).
Diagram 1-8. Chemical structures of the Na+/H+ inhibitors HOE 694 and amiloride, 








o c h 3
chelerythrine
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1.10 Aims of this study
1 . To characterise the effects of PGF2a in Langendorff perfused, non-working rat 
hearts, and to ascertain whether similar effects could be induced via FP receptor 
stimulation using the selective FP agonist, cloprostenol.
2 . To characterise the positive inotropic effect of PGF2(X in paced left atria of rats.
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2.1 Animals
Male Wistar rats of 280 - 310g were supplied by the University of Bath Animal 
House.
2.2 Drugs and chemicals
Drug Source Stock and storage
BCECF/AM Calbiochem (Nottingham) dissolved in anhydrous 
DMSO to 5 mM stock and 
stored at -20°C
chelerythrine chloride Calbiochem dissolved in 1:4 dimethyl 
sulphoxide:water to 10 
mM and stored at -20°C
cloprostenol gift from Dr. Robert 
Coleman of Glaxo
dissolved in ethanol to 250 
M-g/ml (5.9 x Iff4 M) and 
stored at 4°C
collagenase (type II) Worthington Biochemical 
Corporation (New Jersey)
4°C
ftira-2/AM Calbiochem dissolved in anhydrous 
DMSO to 5 mM stock and 
stored at -20°C
HOE 694 gift from Dr. H.-J. Lang of 
Hoechst Pharmaceuticals
dissolved in saline to 10 
mM and stored at -20°C
laminin Sigma Chemical Company 
(Poole)
made up to 15-20 |ig/ml in 
KR buffer and stored at - 
20°C
nigericin Sigma Chemical Company dissolved in 95% ethanol 
to 10 mM and stored at 
-20°C
(-) - noradrenaline 
bitartrate salt
Sigma Chemical Company dissolved in saline &
1 mM ascorbic acid before 
use
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(Thame) & Sigma 
Chemical Company
dissolved in 7 parts 
ethanol and 3 parts water 
to 10 mM and stored at 
-20°C
protease (type XIV) Sigma Chemical Company -20°C
Analytical grade chemicals for buffers were purchased from Fisons Scientific 
Equipment (Loughborough) and British Drug Houses (BDH, Poole).
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2.3 Buffers and solutions
2.3.1 Modified Krebs-Henseleit buffer
For:
a) Langendorff perfused hearts
b) isolated atrial preparations
Composition in mM: NaCl 118, D-Glucose 11.6, NaHC03 25, KC14.7, KH2P 0 4 1.2, 
M gS04 1.2, CaCl2 1.23, gassed with 95 % 0 2 : 5 % C 02.
2.3.2 Modified Krebs-Ringer buffer
For:
a) myocyte isolation
b) fluorescent probe loading
c) single myocyte experiments
Composition in mM: NaCl 118.5, NaHC03 14.5, KC1 2.6, KH2P 0 4 1.2, MgS04 1.2, 
D-Glucose 11.1, HEPES 10.0, CaCl2 1.0, made up to pH 7.4 with NaOH for single 
myocyte experiments.
When this buffer was used for dissociating myocytes, it was gassed with 95 % 0 2 : 5 
% C 02, and CaCl2 was excluded or added in nominal amounts (see 2.6.1).
When this buffer was used for loading myocytes with fura-2/AM or BCECF/AM, it 
was supplemented with 0.5 % bovine serum albumin and Ca2+ was omitted.
2.3.3 High K+-nigericin solution
For:
a) myocyte pH* calibration
Composition in mM: KC1 140, MgCl 1, HEPES 20, nigericin 0.01, made up to pH 
6 .8 , 7.2 and 7.6 with NaOH.
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2.4 Isolated perfused rat hearts
This model was used to compare the effects of PGF2a and the selective FP receptor 
agonist, cloprostenol, on contractility, heart rate and coronary tone.
2.4.1 Experimental set up
Rats were anaesthetised with intraperitoneal 100 mg/kg pentobarbitone sodium and 
killed by cervical dislocation. The heart was excised with the aorta intact and 
immediately immersed in ice-cold modified Krebs-Henseleit buffer (see 2.3.1). As 
shown in diagram M-l (see 2.4.3), the aorta was then cannulated so that the heart 
was perfused through its own circulation with buffer under constant flow conditions 
of 10 ml/min at 37°C. The buffer was delivered using a Watson-Marlow flow 
inducer. A 25-gauge needle was inserted into the chamber of the left ventricle to 
drain the perfusion fluid flowing from the Thebesian vessels. Coronary perfusion 
pressure was monitored by a pressure transducer connected to the aortic cannula. 
Developed tension was measured under 2 g resting tension by means of a hook, piece 
of thread and pulley aligned in a single vertical plane attached to the apex of the left 
ventricle at one end and an isometric transducer at the other end. Signals from the 
isometric transducer also triggered a heart rate meter. Traces were recorded with 
either Gould 2400S or Gould RS3400 recorders. Bolus doses of not more than 100 
pi of drugs were introduced through an injection port near the aortic cannula.
2.4.2 Measurements
The contractile response was measured as the difference between the maximum 
developed tension and resting tension, defined as developed tension. Inotropic 
responses are shown as the percentage increase in developed tension. Changes in 
heart rate are stated in beats per minute while changes in perfusion pressure are 
indicated in millimetres of mercury (mmHg).
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2.4.4 Protocols
Dose dependent actions of PGF2(X and cloprostenol (CLO) on contractility, 
heart rate and coronary tone
Bolus doses of PGF2(X or cloprostenol were introduced after the effects of the 
previous dose had worn off.
20 min stabilisation
i) [PGF2a] nmol 0.01 0.03 0.1 0.3 1.0 3.0 10 30 100 300
20 min stabilisation
ii) [CLO] nmol 0.01 0.03 0.01 0.03 1.0
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2.5 Isolated rat left atria
The positive inotropic effect of PGF2a was characterised in the absence of perfusion 
pressure changes in electrically stimulated atria. This positive inotropy was also 
compared to that of noradrenaline.
2.5.1 Experimental set up
The left atrium was dissected from the isolated rat heart and mounted in a 10 ml 
organ bath containing modified Krebs-Henseleit buffer (see 2.3.1) at 30°C. As 
shown in diagram M-2 (see 2.5.3), one end of the atrium was tied to a platinum 
electrode, while the other end was tied to an isometric tension transducer. The 
atrium was field stimulated by platinum electrodes at 0.2 Hz, 1 ms pulse width at 20 - 
40 V, under a resting tension of 500 mg. Developed tension was monitored with a 
Lectromed recorder connected to the isometric tension transducer. Drugs were 
injected into the organ bath with a Hamilton syringe.
2.5.2 Measurements
The contractile response was measured as the difference between developed tension 
and resting tension, defined as developed tension. Inotropic responses are shown as 
percentage increases in developed tension.
Effects on the rate of relaxation were quantified by comparing the ratio of the 
maximal velocity of contraction (+T) and maximal velocity of relaxation (-T), before 
and after PGF2a treatment.
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2.5.3 Diagram M-2. Schematic representation of the isolated rat left atrial 
preparation
modified Krebs-Henseleit 
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2.5.4 Protocols
a) Effects of PGF2a and noradrenaline on atrial developed tension
PGF2ot, its vehicle, and noradrenaline were added into the organ bath when the 
response to the previous dose had stabilised. Addition of PGF2a and noradrenaline 
were done in the reverse order in some experiments to compensate for the larger 
inotropic effect to drugs at the end of the experiment. In some cases, noradrenaline 
was added after the maximum increase in contractility was achieved with PGF2a, to 
see if the noradrenaline-induced increase in contractility was additive to that of 
PGF2a.
hr 1 hr wash 1 hr washttmtt mrnr ffimP
PGF2a PGF2a vehicle noradrenaline
10 pM-10 pM 10 pM-10 pM
b) Effect of PGF2a (10 pM) on the contraction-relaxation cycle duration
Chart speed was increased from 1 mm/min to 100 mm/s, and the contraction- 
relaxation cycle compared in the presence and absence of PGF2a.
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2.6 Isolated rat ventricular myocytes
The contractile effects of PGF2a were studied on enzymatically dissociated rat 
ventricular myocytes. Myocyte shortening was measured with a video image and 
edge detector system, while Ca2+ transients and pH* were monitored 
spectrofluorimetrically in fura-2 and BCECF loaded myocytes respectively. The 
effects of the Na+/H+ exchanger inhibitor, HOE 694, and the PKC inhibitor, 
chelerythrine, on the PGF2orinduced increase in myocyte shortening and pHi were 
also investigated.
2.6.1 Myocyte isolation
Calcium tolerant myocytes were prepared daily by a method reported by Powell et al. 
(1980). Some modifications to their technique were made. The perfusion system 
was primed with 50 ml Ca2+-ffee modified Krebs-Ringer buffer (see 2.3.2), gassed 
with 95% 0 2 and 5% C 02. The isolated rat heart was cannulated and perfused for 
four minutes at 10 ml/min to clear the coronary vessels of blood. After that, the 
heart was perfused with modified Krebs-Ringer buffer containing 100 u/ml 
collagenase (type II), 0.5 u/ml protease (type XIV) and 20 |iM Ca2+ for 15 minutes in 
a recirculating manner.
The digested heart was taken off the cannula, the aorta and atria discarded, and the 
ventricles sliced into four sections. The ventricular tissue was teased apart with 
forceps and gently shaken in 2 0  ml of gassed enzyme solution in a conical flask at 
37°C for five minutes. The myocyte suspension was then filtered through a 100 |xm 
nylon mesh gauze into a centrifuge tube and the filtrate centrifuged at 14 g for five 
minutes. The supernatant containing collagenase was removed and the myocyte 
pellet resuspended in Ca2+-ffee buffer. This centrifugation and resuspension 
procedure was carried out twice. Ca2+ was gradually added to 1 mM to produce 
single Ca2+ tolerant myocytes.
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2.6.2 Myocyte shortening experiments
2.6.2.1 Experimental set up
Single myocytes attached to a 0.1 ml volume laminin (15 pg/ml) coated perfusion 
chamber, were focused under a X 25 objective and the image projected by a camera 
to a video recorder and TV monitor (see 2.6.2.3, diagram M-3). The camera was 
rotated so that the myocyte length was vertical on the monitor. The edge detector 
system (vertical video length interface supplied by Richard Montgomery, National 
Heart and Lung Institute, London) was similar to that described by Harding et al. 
(1988). The edge detector was interposed between the video recorder and monitor, 
and it generated a movable rectangular window on the monitor. The window was 
positioned to enclose the myocyte image from the top to the bottom edges. The 
threshold of contrast between the myocyte edge and outer region was set so that the 
edge of the myocyte appeared white and the background enclosed by the window 
appeared black. The edge detection device monitored the number of television lines 
between the top of the screen and the first point of high contrast within the window 
(top myocyte edge), and from the top myocyte edge to the last point of contrast 
within the window (bottom myocyte edge). Hence, the length of the myocyte and 
myocyte shortening during electrical stimulation could be monitored when the device 
was connected to a chart recorder, and when connected by the RS232 port to the 
computer.
Only rod-shaped, striated, normally quiescent cells that responded to electrical 
stimulation with a rapid twitch were selected for single myocyte recordings. 
Myocytes were field stimulated at a rate of 1 Hz for 1 ms, at a voltage between 20 - 
60 V, with silver chloride electrodes placed about 2 - 4  mm apart. They were 
superfused with 1 mM Ca2+ containing modified Krebs-Ringer buffer (see 2.3.2) at 2 
ml/min. Experiments were done at room temperature (24 - 26°C).
2.6.2.2 Measurements
Computer analysis of the data obtained at selected periods averaged myocyte 
shortening, time to peak shortening, and time to 50% and 90% relaxation over six
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contractions. This was made possible with the computer programs provided by Dr. 
Peter O'Gara and Dr. Sian Harding (National Heart and Lung Institute, London). 
Myocyte length could also be calibrated by chart recorder measurements of graticule 
distances projected onto the monitor. Measurements obtained this way were similar 
to that of the computer measurements. The experiments were also recorded on 
video tape and could be played back through the edge detector device for analysis 
through the chart recorder or the computer.
Shortening of cardiac myocytes following drug treatment is expressed as the 
percentage difference in absolute shortening compared to before drug treatment. For 
example, if a 100 fim long myocyte shortened by 10 fim, and drug treatment 
increased the shortening to 15 |L im , then the increase in shortening was expressed 
either as an increase of 50%, or 150% of control shortening. Six consequent 
shortening events are averaged at the stated time.
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2.6.2.3 Diagram M-3. Schematic representation of the system for measuring 
myocyte shortening
vertical video length 
interface
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2.6.2.4 Protocols
a) Effect of cumulative addition of PGF2a on myocyte shortening
PGF2a was added after the effect of the previous dose reached a plateau, usually after 
10 minutes. Since 3 p,M PGF2(X produced a large increase in myocyte shortening, this 
standard concentration was used in later studies.
15 min stabilisation
[PGF2oJ nM 3 30 300 1000 3000
b) Effect PGF2a on shortening of myocytes loaded with 5 p,M fura-2
Since fura-2 can buffer intracellular Ca2+ (Noble & Powell, 1990), this set of 
experiments was performed to ensure that this concentration of fura-2 used was not 
affecting the PGF2a-induced increase in myocyte shortening. Data from these 






c) Effects of the Na+/H+ exchanger inhibitor, HOE 694 (0.1 and 10 fiM), on 
PGF2ot-induced increases in myocyte shortening
In preliminary experiments, 10 |iM  HOE 694 inconsistently affected basal shortening, 
therefore its basal effects were compared to when it was combined with PGF2a in the 
same myocyte. Noradrenaline (NAd) was added at the end to ensure myocytes in all 
groups had a similar ceiling for shortening.
15 min stb 1 hr 15 min ■  > - 1
i k ir
i) Time matched control PGF2a NAd
3 fiM 300 nM
Materials & M ethods - 5 2
15 min stb 15 min 1 hr wash 5 min
i r ■ "  ■ ■■■■■ ■■




d) Effect of the PKC inhibitor, chelerythrine (2, 3, 5, 10 pM), on basal myocyte 
shortening
These preliminary experiments were done to characterise the contractile effects of 
chelerythrine. The chelerythrine concentration of 2 pM was chosen for later studies, 
based on the results obtained from these experiments. DMSO solution was used in 














chelerythrine 2 pM 
chelerythrine 2 pM
+ PGF2a 3 pM 
+ PGF2a 3 pM
15 min stabilisation 10 min
■ - I  s m *
J
I " ,! 'J
f  T
+ NAd 300 nM 
+ NAd 300 nM 
+ NAd 300 nM
f) Effects of rapid pacing: relationship between the increase in contractility due 
to rapid pacing and that induced by PGF2a
With some batches of myocytes, prolonged stimulation at 1 Hz caused the myocyte 
under observation to develop a contracture, and therefore the experiment was 
terminated.
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In order to identify better myocytes, myocytes were paced at 2 Hz for one minute at 
the beginning of an experiment. Those myocytes that could follow the pacing train, 
and survive this procedure, were usually capable of lasting for the duration of the 
experiment. The changes in myocyte shortening during rapid pacing and that with 
PGF2a treatment were noted.
1 m in
i I; i "H
1 Hz 2 Hz 1 Hz PGF2a
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2.6.3 Ca2+ andpH t fluorescence experiments
The advent of fluorescent agents that change their spectral properties upon binding 
the ion of interest such as Ca2+ (e.g. by fiira-2 or indo-1), or H* (e.g. by BCECF or 
SNARF) allow the concentrations of these ions to be followed in the intact myocyte. 
In this study, fura-2 and BCECF were used to monitor intracellular Ca2+ and pH 
respectively. They are introduced into the myocyte as the hydrophobic 
acetoxymethyl (AM) ester form which passes through the sarcolemmal membrane. 
Once inside the myocyte, intracellular esterases cleave the ester, leaving the agent in 
the cytosol. The myocyte is illuminated with the appropriate excitation wavelength, 
fluorescence at the emission wavelength monitored, and the concentration of the ion 
calculated according to the calibrated fluorescence ratio.
With fura-2, binding of Ca2+ causes a hypsochromic shift (shift to a shorter 
wavelength) of the excitation spectra. As a result, fluorescence intensity increases at 
an excitation wavelength of 340 nm but decreases with excitation at 380 nm, when 
monitored at an emission wavelength of 510 nm (Grynkiewicz et aL, 1985). The 
signal ratio of 340/380 is linearly proportional to the concentration of the fluorescent 
species as fura forms a 1:1 complex with Ca2+. The fura-2 transient arising from each 
electrical stimulation represents cytosolic free Ca2+, and is dependent on all the 
processes contributing to, and removing Ca2+ from the cytosol as described earlier in 
section 1.3. Additionally, while allowing small changes in the Ca2+ level to be 
detected, the ratiometric method is reported to eliminate artifacts arising from total 
dye concentration, dye leakage, cell thickness, or absolute sensitivity of the 
instrument (Grynkiewicz et al., 1985). Problems encountered with this method 
include photobleaching, compartmentation of dye into intracellular organelles and 
incomplete hydrolysis of ester groups producing Ca2+ insensitive intermediates.
The same principle is used with BCECF when measuring intracellular pH. The 
BCECF loaded myocyte is illuminated with excitation wavelengths of 440 and 490 
nm. At the emission wavelength of 535 nm, the fluorescence intensity at the 
excitation wavelength of 490 nm increases with increasing pH, while that at 440 nm 
remains the same (isobestic point). Hence, the 490/440 ratio increases linearly with 
pH within the range of around pH 6.5 - 7.5 (Rink et al., 1982). This linear
Materials & Methods - 55
relationship is exploited in the calibration procedure, which involves perfusing the 
myocytes with high K+ and nigericin (H+/K+ antiporter, Thomas et al., 1979) 
containing calibration solutions of different pH values (see 2.3.3). Hence, the pHi of 
each myocyte can be determined by a linear regression of the fluorescence ratio 
versus the pH value of the calibration buffer (Borzak et al., 1990). The high 
potassium is required to eliminate membrane potential.
2.6.3.1 Fura-2/AM or BCECF/AM loading
Myocytes were loaded with the Ca2+ sensitive fluorescent dye, fura-2/AM, by 
incubating a 2.5 - 5 ml aliquot (about 1/20 of the myocyte yield) of myocytes with 5 
(iM fura-2/AM and 0.5 % bovine serum albumin in Ca2+ free Krebs-Ringer buffer 
(see 2.3.2). These myocytes were kept at 37°C for 30 minutes in an aluminium foil 
enclosed centrifuge tube. Removal of extracellular fura-2/AM and gradual exposure 
of the myocytes to Ca2+ was performed with three times centrifugation (14 g, 5 min) 
and resuspension with 0.1, 0.6 and 1 mM Ca2+-containing modified Krebs-Ringer 
buffer. Similar procedures were carried out when the myocytes were loaded with the 
pH sensitive fluorescent dye, BCECF/AM, except that myocytes were loaded with 2 
- 3 pM dye at room temperature for 20 minutes.
2.6.3.2 Experimental set up
Isolated myocytes, attached to a 0.1 ml volume laminin-coated perfusion chamber, 
were observed under a X 40 oil immersion objective on an inverted Nikon Diaphot 
300 microscope in a darkened room. Only rod-shaped, striated, fluorescent, 
normally quiescent myocytes that responded to stimulation with a rapid twitch were 
selected for single myocyte recordings. These myocytes were field stimulated at a 
rate of 1 Hz for 1 ms, at a voltage between 20 - 80 V, with silver chloride electrodes 
placed about 2 - 4  mm apart. Experiments were done at room temperature (24 - 
26°C), and myocytes were superfused with 1 mM Ca2+-containing modified Krebs- 
Ringer buffer (see 2.3.2) at 2 ml/min.
Experiments were done with a Deltascan dual monochromator Photon Technologies 
International spectrofluorimeter system (see 2.6.3.4, diagram M-4).
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Autofluorescence was first measured from a non-myocyte area similar in size to that 
of the selected myocyte. The viewed area on the photometer arm could be adjusted 
with movable slits. The fura-2 loaded myocyte was then brought into view and 
alternately excited with 340 and 380 nm wavelengths, and the fluorescence detected 
at the emission wavelength of 510 nm. The excitation light was reflected to the 
myocyte by a dichroic mirror placed under the objective, and the resulting 
fluorescence from the myocyte transmitted back to the dichroic mirror and towards 
the photomultiplier at the end of the photometer arm. Autofluorescence signals were 
then subtracted from the experimental signals, before data were analysed by Photon 
Technologies International computer software.
Measurements of pH* were done in a similar way. BCECF loaded myocytes were 
electrically stimulated and alternately excited with 440 and 490 nm wavelengths. 
Fluorescence was detected at an emission wavelength of 535 nm. pH* was calibrated 
for each myocyte, but whenever it was not possible to do so (e.g. myocyte washed 
away), calibrations were carried out with another myocyte from the same batch. 
Myocytes were perfused with a high K+ and nigericin solution (see 2.3.3) of pH 6.8, 
pH 7.2, and pH 7.6, in random order.
2.6.3.3 Measurements
Ca2+ measurements were obtained at 50 ms intervals. Diastolic fura-2 340/380 ratio 
represents diastolic Ca2+ level, while the amplitude of the 340/380 ratio spike 
represents the difference between the systolic and diastolic Ca2+ concentration. Ten 
Ca2+ transients before, and at the stated time after addition of a drug, were first 
averaged in each myocyte. These values were then averaged to those found with 
other cells.
The duration of the 340/380 ratio spike amplitude was measured at 5% of the 
amplitude value above the diastolic level. This value was first averaged over ten 
spikes for each myocyte, and then averaged for all myocytes. BCECF signals were 
only recorded for 10 s at 1 min intervals over the duration of the experiments to 
minimise photobleaching of BCECF. Signals were averaged to two points for every
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3 s, and calibrated by linear regression of the 490/440 ratio versus the pH value of 
the calibration buffer.
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2.6.3.4 Diagram M-4. Schematic representation of the system for measuring 
myocyte fluorescence
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2.6.3.5 Protocols for Ca2+ transient experiments
a) Effects of noradrenaline on Ca2+ transients
The effects of noradrenaline on Ca2+ transients were characterised so that it could be 
used as a positive control.
5-15 min stabilisation
b) Effect of PGF2a on Ca2+ transients
Ca2+ transients in the presence of PGF2a were monitored with the protocol below. In 
some experiments, PGF2a was washed out for 12 minutes, and noradrenaline was 
added for 100 seconds. Data from these experiments were also used to construct 








PGF2a 3 pM 
vehicle
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2.6.3.6 Protocols for pHj experiments
a) pHj calibration
High K+-nigericin solutions of different pH were added in random order and the 
BCECF fluorescence ratio recorded.
experimental pH 6.8 pH 7.2 pH 7.6
procedure high K+-nigericin solution
b) Effect of PGF2a on pHj




i) PGF2a 3 P-M pHj calibration
ii) vehicle pH; calibration
c) Effect of the Na+/H+ inhibitor, HOE 694, on PGF2a-induced increase of pHi
5-15 min stb. 24 min wash
i
r 1
i) PGF2a 3 pM  + H O E  694 10 pM p H j  calibration
ii) H O E  694 lOpM p H j  calibration
d) Effect of the PKC inhibitor, chelerythrine, on PGF2a-induced increase of pHj
5-15 min stb. 10 min ______________ ^
i l i
i) DMSO +PGF2a 3 pM  pHj calibration
ii) chelerythrine 2  pM  + P G F 2 a  3 pM p H i  calibration
iii) chelerythrine 2 pM  chelerythrine 2 pM  p H i  calibration
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2.6.4 Phase-plane diagram
A method for assessing changes in the sensitivity of the myofilaments to Ca2+ in 
intact myocytes was described by Spurgeon et al. (1992). They argued that during 
the late phase o f relaxation, equilibrium conditions between Ca2+ binding and 
contraction exist, which is a prerequisite for the determination of myofilament 
sensitivity to Ca2+. When myocyte length is plotted with respect to Ca2+ during a 
contraction, a loop or phase-plane diagram results (diagram M-5). Loops proceed in 
a counter-clockwise direction, and arrows on each trajectory represent 50 ms 
isochrones. The loop going upwards represents contraction, and the loop going 
downwards represents the relaxation phase. A shift of the late relaxation phase 
upwards and leftwards represents an increase in Ca2+ sensitivity (diagram M-6), while 
that downwards and rightwards indicates a reduction in Ca2+ sensitivity. This is 
demonstrated with the Ca2+ sensitisers EMD 53998, NFLCl-induced alkalosis and 
phenylephrine, as well with the Ca2+ desensitisers butanedione monoxime and 
isoprenaline (Spurgeon et al., 1992; Gambassi et al., 1992).
Diagram M-5. A, simultaneously measured [Ca2+], and cell length following 
stimulation from rest of a representative single rat myocyte that had been loaded with 
the free acid form of Indo-1. B, the initial transients in A are depicted with greater 
resolution. C, phase-plane trajectories of cell length-[Ca2+], for the transients in A 
(loops proceed in a counter-clockwise direction). Although the individual 
contractions and [Ca2+] transients vary in magnitude, a common trajectory occurs 
during relaxation. Modified from Spurgeon et al. (1992).
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Diagram M-6. Simultaneously measured Indo-1 fluorescence transients and 
contractions in a representative rat myocyte stimulated at 0.5 Hz prior to and 
following addition of the Ca2+ sensitising drug, EMD 53998, to the bath. B, cell 
length-fluorescence phase-plane trajectories for transients in A. C, autoscaled 
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2.6.4.1 Plotting of the phase-plane diagram
An accurate assessment by this method requires that myocyte length and Ca2+ be 
measured simultaneously, which I was unable to do with the equipment available. 
Nevertheless, data of myocyte shortening and Ca2+ transients already obtained from 
previous separate experiments (see 2.6.2.4b and 2.6.3.5b) were used to construct a 
phase-plane diagram to investigate if PGF2a sensitises myofilaments to Ca2+.
The twitch and Ca2+ were synchronised so that the difference in time to peak Ca“+ 
and shortening was 100 ms. This time lag period was selected because fura-2 ratios 
were obtained at 50 ms intervals, and because the lag period approximates to that 
found previously (Spurgeon et a l., 1992).
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2.7 Statistical analyses
Values are expressed as means ± standard error of means. They are considered 
significant when the probability, P < 0.05. Where variances were equal, statistical 
analysis was carried out using one-way ANOVA for differences between groups, and 
two-way ANOVA for differences within groups. Significance from the control 
group was determined with Dunnett's method. Paired comparisons within groups 
were carried out with the one sample Student's f-test.
When variances were unequal (P < 0.05, Bartlett's test of equal variances), associated 
non-parametric methods were utilised. The Mann-Whitney U test with Bonferroni 
correction, after the Kruskal-Wallis ANOVA method, was used for multiple 
comparisons between groups. In cases where paired data were compared, the 
Wilcoxon signed rank test was used. Data were tabulated by computer using the 
statistical analyses package, Minitab for Windows (1994), State College PA.
Results from experiments with single myocytes were usually obtained from one to 




3.1 Isolated perfused rat hearts
This modified Langendorff whole heart model was used to study the effects of PGF2a 
and the FP receptor agonist, cloprostenol, under constant flow conditions.
a) Effects of PGF2(X and cloprostenol on contractility, perfusion pressure and 
heart rate
PGF2a increased the contractility of the heart in a biphasic manner at doses between 
0.01 to 300 nmoles (figures 1 & 3A). Figure 1 shows a small transient increase in 
contractility which is more prominent at higher doses, preceding a prolonged 
response to PGF2a. A transient decrease in contractility occurred before the 
increases in contractility. The ED50 value was not determined as a plateau was not 
achieved, although two hearts out of six did show a maximum response at 1 0  nmoles.
Similarly, the inotropic effect of cloprostenol between 0.01 to 1 nmole was biphasic 
(figure 2). However, cloprostenol was more potent than PGF2a as the cloprostenol 
dose response curve shown in figure 3A is to the left of the PGF2a dose response 
curve. For example, cloprostenol increased developed tension by 26.7 ± 4.1 % (n = 
8 ) at 0.1 nmoles while PGF2a increased developed tension by only 7.7 ± 3 % (n = 6 ) 
at the same dose (p < 0.05, one-way ANOVA). Also, the response to cloprostenol 
lasted longer than that of PGF2ot.
There was a transient vasoconstrictor effect prior to vasodilation in response to 
PGF2a (figures 1 & 3). In contrast, only a clear vasodilator action was apparent with 
cloprostenol within the dose range tested (figures 2 & 3).
Figures 1 and 2 show that there was no consistent change in heart rate with either 
drug.
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Figure 1. Typical trace showing the effects of PGF2a on developed tension (DT), 
heart rate (HR) and coronary perfusion pressure (PP) in isolated rat hearts. One of 
six similar experiments.
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Figure 2. Typical trace showing the effects of cloprostenol on developed tension 
(DT), heart rate (HR) and coronary perfusion pressure (PP) in isolated rat hearts. 
One of eight similar experiments.
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Figure 3. Dose response relationships of PGF201 and cloprostenol on (A) developed 
tension, (B) initial vasoconstriction and (C) vasodilation in isolated rat hearts. Basal 
developed tension, heart rate and perfusion pressure was 9.6 ± 0.7 g, 338 ± 17 
beats/min and 90 ± 10 mmHg respectively with PGF2a, and 8.0 ± 0.4 g, 289 ± 8 
beats/min and 75 ± 5 mmHg respectively with cloprostenol.
A —•— PGFj,,, n = 6
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3.2 Isolated rat left atria
Since PGF2a increased and decreased coronary perfusion pressure in the whole heart, 
these effects may have influenced the changes in contractility. In order to study 
contractility in the absence of perfusion pressure changes, electrically stimulated rat 
left atria were used.
a) Effects of PGF2a and noradrenaline on developed tension
PGF2a increased developed tension of the electrically stimulated left rat atria in a 
concentration dependent manner, with maximal effects occurring at 1 pM (figures 4 
& 5). Figure 5 shows that it was more potent than noradrenaline, as there is a clear 
shift between their responses. Effects of further concentrations of noradrenaline 
above 10 pM were not recorded because of an increase in ectopic activity in four out 
of six atria. In three out of these six experiments, noradrenaline was added in the 
presence of 10 pM PGF2a, a concentration which produced a supramaximal 
response. This resulted in a further increase in developed tension (figure 6), showing 
that at least part of their mechanisms of action were different.
b) Effect of PGF2a on the duration of the contraction-relaxation cycle
Figure 7 shows the superimposed effects of different concentrations of PGF2a on the 
atrial contractile response at a faster chart speed. Time to peak contraction was not 
altered but relaxation was prolonged by PGF2a. This negative lusitropic effect of 
PGF2a is quantified in figure 8. A proportionally smaller increase in the maximal 
velocity of relaxation (-T) compared to the maximal velocity of contraction (+T) 
occurred with 10 pM PGF2a, that is, the ratio +T/-T was significantly increased.
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Figure 4. Typical trace showing the effects of PGF2a and noradrenaline on developed 
tension (DT) of the same rat left atria. One of six similar experiments. Note the 
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Figure 5. Concentration dependent relationships of PGF2tt, its vehicle control, and 
noradrenaline on the contractility of the same rat left atria.
—o — PGF2a vehicle 
—* — noradrenaline














Figure 6. Histogram of the effect of noradrenaline (NAd) on the maximum increase 
in contractility induced by PGF2a in rat left atria
PGF2a 10 gM PGF2 a 10gM
+ NAd 1 hM
PGF2a10gM  
+ N A d 1 0 nM
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Figure 7. Superimposed traces of the effects of PGF2a on the contraction-relaxation 
cycle of rat left atrium.
1 x 1 0  M PGF2a 





Figure 8. Histogram of the effects of PGF2a on the ratio of the maximum rate of 
contraction (+T) and the maximum rate of relaxation (-T) of rat left atria. * p < 0.05, 
Wilcoxon signed rank test.
Control PGF2a 
1 0  p.M
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3.3 Isolated rat ventricular myocytes
The mechanism of action of PGF2a was studied at the cellular level using dissociated 
rat ventricular myocytes, which are devoid of neural and humoral influences. Edge 
detection was used to study myocyte shortening, while fluorimetric probes fura-2 and 
BCECF were used to monitor intracellular Ca2+ and pH respectively. Figure 9 shows 
a typical myocyte used in the experiments.
3.3.1 Myocyte shortening experiments
a) Effects of PGF2a
Figures 10 and 11 show the concentration dependent increase in myocyte shortening 
of up to 39.6 ± 3.4% with cumulative addition of PGF2a to 3 pM (n = 4). 
Additionally, myocyte diastolic length was reduced to 94.3 ± 1.5% of basal length 
with 3 pM PGF2a. Both these effects were reversible upon wash out of the drug. In 
contrast to results obtained from the atrial preparation (see 3.2b), there was no 
significant change in the duration of the contraction-relaxation cycle in ventricular 
myocytes (figures 12 & 13).
b) Effects of fura-2
As fura-2 was to be used to measure intracellular Ca2+ (see 3.3.2), some experiments 
were done to see if fura-2 affected the contractile response to PGF2oc. Figures 10B & 
14 show the increase in myocyte shortening induced by a single concentration of 3 
pM PGF2a in fura-2 loaded myocytes. This increase of 40.4 ± 10.7% (n = 7) was 
similar to that obtained from fiira-2 non-loaded myocytes when PGF2ot was added 
cumulatively (39.6 ± 3.4%, n = 4, see 3.3.1a above), indicating that fura-2 was not 
reducing the increase in myocyte shortening induced by PGF2a.
In response to a single concentration of 3 pM, the change in myocyte shortening was 
either mono- or bi-phasic; three out of seven fura-2 loaded myocytes showed a 
transient decrease in shortening before the sustained increase in shortening. Similar 
biphasic effects were seen in myocytes which were not loaded with fura-2 in later 
experiments (figures 28A and 33A). Not all stably shortening myocytes responded
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to PGF2a as one out of seven fura-2 loaded myocytes was unresponsive to 3 pM 
PGF2ot. In responding myocytes, the increase in shortening reached a maximum 
between 5 to 16 minutes. On washout of PGF2a, recovery from the increase in 
shortening was seen in four myocytes. The time course of the contraction-relaxation 
cycle was unaffected in the presence of PGF2a and fura-2 (figure 15).
c) Relationship between the changes in shortening induced by rapid pacing and 
that induced by PGF2ot
In some myocyte batches, the stimulation rate was increased from 1 Hz to 2 Hz and 
then restored again to 1 Hz to check if the myocyte was likely to last the whole 
experimental protocol (see 2.6.2.4f). Myocytes that could follow the stimulation 
train and survive this procedure were used for experiments.
When myocytes were subjected to the pacing protocol described above and followed 
by the addition of 3 pM PGF2a, a significant correlation between the 
increase/decrease in myocyte shortening due to rapid pacing and that induced by 
PGF2a was observed, P = 0.02 (figure 16). This suggests that there may be a 
similarity between both the mechanisms. This observation was later used to ensure 
that myocytes in all groups during an experiment had similar basal responses to 
PGF2a (see 3.3.5c).
In a separate group of experiments, the same rapid pacing protocol was used to 
determine the proportion of myocytes that displayed the different contractile effects 
during rapid pacing (staircase effects). In a total of 50 myocytes from four hearts, 34 
myocytes showed a positive staircase (increased shortening), 4 showed a flat 
staircase (no change), while 12 myocytes showed a negative staircase (decreased 
shortening).
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Figure 10. Typical traces showing the effects of PGF201 in rat ventricular myocytes 
not loaded with fura-2 (A) and that loaded with fura-2 (B). One of four and seven 
similar experiments respectively.
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Figure 11. Concentration dependent effects of cumulative addition of PGF2a on 
shortening (A) and diastolic length (B) of rat ventricular myocytes. Basal shortening 
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Figure 12. Concentration dependent effects of cumulative addition of PGF2a on the 
rat ventricular myocyte contraction-relaxation cycle.
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Figure 13. Concentration dependent effects of cumulative addition of PGF2a on rat 
ventricular myocyte time to peak shortening, TTP (A), time to 50% relaxation, R50 
(B) and time to 90% relaxation, R90 (C).
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Figure 15. Effects of PGF2o on the fura-2 loaded rat ventricular myocyte time to 
peak shortening, TTP (A), time to 50% relaxation, R50 (B), and time to 90% 
relaxation, R90 (C).
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Figure 16. Correlation between the increase in shortening induced by PGF2tt and that 
by increasing pacing frequency in rat ventricular myocytes (refer to protocol 
2.6.2.4f). Pearson correlation = 0.623, P= 0.02.
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3.3.2 Ca2+fluorescence and Ca2+ current experiments
Electrical stimulation of fura-2 loaded myocytes caused a rapid increase and a 
gradual decline in the fura-2 340/380 fluorescence ratio with each myocyte 
shortening. Noradrenaline was used in preliminary experiments as a positive control 
to show that changes in Ca2+ transients could be detected before the effects of PGF2a 
were tested. The amplitude of the Ca2+ transients, diastolic Ca2+ and duration of the 
transient decay were recorded. Ca2+ currents were also recorded in PGF2a-treated 
myocytes patch-clamped in the whole cell configuration.
a) Effects of noradrenaline on Ca2+ transients
Noradrenaline (0.03 & 300 nM) increased the amplitude of the 340/380 fluorescence 
ratio in fura-2 loaded myocytes, and this is shown in figures 17 and 18. Also, 
diastolic 340/380 ratio was transiently reduced with 300 nM noradrenaline before a 
sustained significant increase occurred (figure 18). The duration of the Ca2+ 
transients was attenuated at the point of 5% of the peak amplitude above the 
diastolic level (figures 17 & 21). Therefore, changes in myocyte intracellular Ca2+ 
levels were detectable spectrofluorimetrically and 300 nM noradrenaline was used as 
a positive control.
b) Effect of PGF2a on Ca2+ transients
PGF2a, at a concentration of 3 pM that produced a marked increase in myocyte 
shortening, did not significantly increase the amplitude or change the diastolic 
340/380 fluorescent ratio of nine fura-2 loaded myocytes within seven minutes 
(figures 17, 19 & 20). Duration of the Ca2+ transients was also not significantly 
changed (figures 17 & 21). In three of these myocytes, washout of PGF2ot and 
superfusion of these same myocytes with 300 nM noradrenaline produced a clear 
increase in the amplitude of the 340/380 ratio with an initial decrease followed by 
recovery of the diastolic 340/380 ratio (figure 20). These results indicate that 
although no change in the Ca2+ transients was seen with PGF2a, the myocytes were 
capable of responding to agonists that increase intracellular Ca2+ levels.
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c) Effect of PGF2a on L-type Ca2+ currents
Dr. Katherine Reeves measured L-type Ca2+ currents in myocytes patched clamped in 
the whole cell configuration. PGF2a(100 nM) did not affect the Ca2+ current of 
these myocytes, but addition of isoprenaline (100 nM) at the end of the experiment 
did increase the Ca2+ current (figure 22).
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Figure 17. Superimposed traces showing the effects of PGF2a and noradrenaline on Ca2+ 
transients from the same rat ventricular myocyte. One of three similar experiments.
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Figure 18. Effects of noradrenaline on the intracellular Ca2+ level in rat ventricular 
myocytes. This is shown by changes in the amplitude (A) and diastolic (B) fura-2 
340/380 ratio. ** P < 0.01 with respect to time = 50s (two way ANOVA with 
Dunnett’s test for multiple comparisons).
— ■— noradrenaline 300 nM, n = 8 
— o— noradrenaline 0.03 nM, n = 8
— A— vehicle, n = 8
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Figure 19. The lack of effect of PGF2tt and its vehicle with respect to the amplitude 
(A) and diastolic (B) fura-2 340/380 ratio of rat ventricular myocytes.
• — PGF2a 3 tiM, n = 9 
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Figure 20. Effects of PGF2a and its vehicle on the amplitude (A) and diastolic (B) 
fura-2 340/380 ratio of rat ventricular myocytes. In these experiments, noradrenaline 
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Figure 21. Histogram indicating the change of the duration of the Ca2+ transient by 
noradrenaline but not by PGF2ct in rat ventricular myocytes. This was measured as 
the duration of the fura-2 340/380 ratio spike width at 5% of the amplitude value 
above basal after 100 s with noradrenaline and its vehicle, or after 7 min with PGF2a 
and its vehicle. *** P< 0.001, paired r-test.
800-.
700-
1 I Before drug/vehicle 
I B  After drug/vehicle
600-
_ 5 0 0 -
7/T
£  






noradrenaline noradrenaline 3 PGF2a vehicle
300 nM vehicle
n = 8 n = 8 n = 9 n = 9
Results - 9 2
Figure 22. Typical trace of the effects of PGF2a and isoprenaline on the L-type Ca2+ 
currents in the same rat ventricular myocyte. One of three similar experiments where 
isoprenaline was added at the end of the experiment. Myocytes were patch clamped 
in the whole cell configuration at 32°C and Ca2+ currents elicited by depolarising the 
cell every 20 s from a holding potential of -80 mV to 0 mV for 200ms. Fast Na+ 
currents were eliminated using a pre-pulse to -40 mV for 40 ms prior to the test 
pulse. This work was done by Dr. Katherine Reeves.
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3.3.3 Effect of PGF2a on the phase-plane diagram
Data from the Ca2+ transient and myocyte shortening experiments were plotted 
together with respect to time, resulting in a phase-plane diagram which gave an 
indication of the Ca2+ sensitivity of the myofilaments. It should be noted that 
Ca2+/myocyte shortening recordings were not taken from the same cells. However, 
figure 23 shows that PGF2a (3 |iM) did shift the late phase of relaxation upwards and 
to the left when compared to control.
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Figure 23. Effect of PGF2a on the late phase of relaxation of the phase-plane 
diagram from data obtained from rat ventricular myocytes. Each arrow represents a 
50 ms isochrone. Standard error of means are omitted for clarity.
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Previous experiments in fura-2 loaded myocytes showed that PGF2a did not increase 
Ca2+ transients. Therefore, the possibility that PGF2a increased myocyte shortening 
by increasing intracellular pH arose because some positive inotropic agents do not 
affect Ca2+ transients but do increase intracellular pH. Alkalosis has been reported to 
alter Ca2+ sensitivity of contractile proteins (Fabiato & Fabiato, 1978), so this 
possibility was investigated in BCECF loaded myocytes treated with PGF2ot.
a) Calibration of pH(
The BCECF 490/440 ratio was linearly related to pH between pH 6.8 to 7.6 when 
calibrated with the nigericin method. This is shown in figure 24, where R = 0.99, p = 
0.005.
b) Effect of PGF2a on pHi
Figures 25 and 26 show that 3 fiM PGF2ot increased pH* of BCECF loaded myocytes 
by 0.08 ± 0.01 pH units. This effect was reversible upon wash out. This intracellular 
alkalosis occurred at a similar time course to that of the increase in myocyte 
shortening seen in the fura-2 loaded myocytes in separate experiments (figure 27). In 
contrast, time matched vehicle controls showed a gradual decline in myocyte pHi of 
about 0.003 units/min (figure 26).
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Figure 24. (A) Typical calibration trace of myocyte pHj. One of 34 similar 
experiments. (B) Change of the 490/440 BCECF ratio with respect to pH by the 

















Results - 9 7
Figure 25. Typical trace of the effect of PGF2 a on pH* of BCECF loaded rat 
ventricular myocytes, one of five similar experiments. Measurements were taken at 1 
min intervals for a 10 s duration during a 40 min period. Inserts (A) and (B) show 




Figure 26. Effect of PGF2a on pHj of BCECF loaded rat ventricular myocytes. 
Wash out of PGF2a after t = 16 min reversed its effect on pHj. pH* was standardised 
at the start of PGF2a addition. * p  < 0.05 compared to its corresponding vehicle time 
matched controls, one-way ANOVA.
—• — PGF2a3 nM, basal pH, = 7.17 +/- 0.05, n = 5
►—  Vehicle, basal pH, = 7.21 +/- 0.03, n = 5
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Figure 27. Time course effects of PGF2o (3 p.M) on pHj of BCECF loaded rat 
ventricular myocytes and shortening of fura-2 loaded rat ventricular myocytes. 
Myocyte shortening and pHj was standardised at the start of PGF2a addition.
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3.3.5 Effect o f  inhibitors on the PGF2arinduced increase in myocyte shortening 
and pHi
The previous section showed that PGF2a increased myocyte pHi. Therefore, the next 
sets of experiments were done to find out if this increase in pH* stemmed from 
activation of the Na+/H+ exchanger and if PKC was involved. HOE 694 was used to 
inhibit the Na+/H+ exchanger (Scholz et al., 1993; Loh et al., 1996), while 
chelerythrine was used to inhibit PKC (Herbert et al., 1990). Most importantly, 
whether the PGF2a-induced alkalosis could cause the positive inotropy was 
investigated, since alkalosis is known to sensitise the myofilaments to Ca2+ (Fabiato 
& Fabiato, 1978). In separate sets of experiments, the effects of HOE 694 and 
chelerythrine on PGF2a-induced myocyte shortening were also studied.
a) Effects of HOE 694 on myocyte shortening
The Na+/H+ exchanger inhibitor, HOE 694, inhibited the increase in myocyte 
shortening induced by PGF2oc in a concentration dependent manner (figures 28 & 29). 
HOE 694 at 0.1 pM (a concentration close to the IC50 value, Scholz et al., 1993) did 
not have any effect on basal myocyte shortening, but it reduced the PGF2a-induced 
increase in shortening. At a higher concentration of 10 pM, HOE 694 inconsistently 
increased myocyte shortening, but abolished that induced by PGF2a.
Additionally, washout of 10 pM HOE 694 produced a transient potentiation of 
myocyte shortening. This effect parallelled a transient rise in pHi (see 3.3.5b below 
and figure 30).
The addition of noradrenaline (300 nM) at the end of the experimental protocol 
increased shortening in all groups, showing that these myocytes had a similar ceiling 
for shortening (figure 29).
b) Effects of HOE 694 on myocyte pHj
Figure 30 shows that HOE 694 (10 pM) did not affect pHi of BCECF-loaded 
myocytes but it did abolish the alkalosis induced by 3 pM PGF2a. Wash out of HOE 
694 however, transiently raised pHi by 0.05 ± 0.02 units (n = 4) after nine minutes,
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and a larger increase of up to 0.10 ± 0.01 units (n = 5) was found when PGF2a was 
also initially present with HOE 694.
c) Effect of chelerythrine on myocyte shortening
Preliminary experiments showed that when chelerythrine was given alone, it 
augmented myocyte shortening in a concentration dependent manner (2 to 10 |iM) 
while its vehicle, 1 part DMSO to 4000 parts water, did not (figures 31 & 32). 
Chelerythrine has an IC50 value of 0.66 pM for PKC inhibition (Herbert et al., 1990). 
Therefore, a chelerythrine concentration of 2 pM was chosen for the PGF2a 
experiments as this was about three times the IC50 value but which did not affect 
basal myocyte shortening.
Myocytes were preselected so that the increase in shortening with rapid pacing (see 
2.6.2.4f and 3.3.1c) was similar in both the PGF2a time matched control group and in 
the group where the PKC antagonist, chelerythrine was added with PGF2a (31.8 ± 
3.7% vs. 32.8 ± 5.7% increase, n = 6/group). The shortening response induced by 3 
pM PGF2a was significantly less in the presence of 2 pM chelerythrine compared to 
PGF2(x time matched controls (figures 33 & 34). Noradrenaline (300 nM) added at 
the end of the experimental protocol increased myocyte shortening similarly in all 
groups (figure 34).
d) Effects of chelerythrine on myocyte pHi
The PKC inhibitor, chelerythrine, did not modify myocyte pH* at 2 pM, but the 
alkalosis induced by 3 pM PGF2ot was significantly less in the presence of this 
concentration of chelerythrine (figure 35). Higher concentrations of chelerythrine 
were not used as they increased basal myocyte shortening (see 3.3.5c above).
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Figure 28. Typical traces of the effects of HOE 694 on the increase in myocyte 
shortening induced by PGF2a in rat ventricular myocytes. Trace (B) shows that HOE 
694 at 0.1 pM reduced the PGF2a-induced shortening increase as seen in trace (A), 
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Figure 29. Histogram showing the effects of HOE 694 on the increase in myocyte 
shortening induced by PGF2a in rat ventricular myocytes. * P < 0.05 Wilcoxon 
signed rank test, # P< 0.05 Mann-Whitney U test.
n = 5-6 /group
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Figure 30. The effect of HOE 694 on the intracellular alkalosis induced by PGF2a in 
BCECF loaded rat ventricular myocytes. Wash out of HOE 694 was associated with 
a transient increase in pHj. pHj was standardised at the start of drug perfusion. * f  < 
0.05 (•) vs. (o ) , # P< 0.05 (A) vs. (o), one-way ANOVA.
— PGF2a 3 iiM, basal pH, = 7.17 +/- 0.05, n = 5 
—o— PGF2a vehicle, basal pH, = 7.21 +/- 0.03, n = 5 
—a— PGF2a 3 gM + HOE 694 10gM, basal pH, = 7.28 +/- 0.04, n = 5
—a—  HOE 694 10 pM, basal pH, = 7.25 +/- 0.05, n = 4
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Figure 31. Typical traces showing the effects of chelerythrine and its vehicle, 
DMSO, on rat ventricular myocyte shortening. Data were obtained after 5 min 
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Figure 32. Histogram showing the effects of chelerythrine on rat ventricular myocyte 
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Figure 33. Typical traces showing the effect of chelerythrine on the increase in 
myocyte shortening induced by PGF2ot in rat ventricular myocytes. Trace (A) shows 
that the vehicle for chelerythrine (DMSO solution) did not affect the PGF2„-induced 
increase in myocyte shortening, while chelerythrine reduced it in trace (B). 
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Figure 34. Effects of chelerythrine on the increase in myocyte shortening induced by 
PGF2a in rat ventricular myocytes. * P  < 0.05 Wilcoxon signed rank test, # < 0.05
Mann-Whitney U test.
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Figure 35. Effect of chelerythrine on the intracellular alkalosis induced by PGF2a in 
BCECF loaded rat ventricular myocytes. pH; was standardised at the start of PGF2tt 
addition. # P <  0.05 (•) vs. (A), * P < 0.05 (A) vs. (•), Kruskal-Wallis test, then 
Mann-Whitney U test.
— a — C h e l e r y t h r i n e  2 pM, p H j =  7.16 ± 0.04 at t = 11 min, n = 6  
— PGF2a 3 pM, pHj = 7.16 ± 0.07 at t = 11 min, n  = 6
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4.1 Summary of primary results
The PGF2orinduced increase in cardiac contractility could have occurred either by an 
increase in intracellular Ca2+ or by an increase in the sensitivity of the contractile 
filaments to Ca2+. This study showed that PGF2a increased myocyte shortening 
without increasing intracellular Ca2+ in experiments where Ca2+ transients were 
monitored in fura-2 loaded rat ventricular myocytes. Instead, it appeared to activate 
the Na+/H+ exchanger, as the resulting intracellular alkalosis shown in BCECF loaded 
myocytes was abolished by the exchanger inhibitor, HOE 694. Since HOE 694 also 
inhibited the PGF2a-induced increase in myocyte shortening, this suggests that the 
alkalosis sensitised the contractile filaments to Ca2+, leading to the positive inotropic 
effect.
Discussion - 1 1 2
4.2 Comparison of the effects of cloprostenol and PGF^
PGF2a and cloprostenol increased the contractility of isolated perfused rat hearts, 
with cloprostenol being more potent than PGF2a (figure 3). Since both these drugs 
are known agonists of the FP prostaglandin receptor (Coleman et al., 1994), this 
suggests that the increase in contractility produced by PGF2a may be FP receptor 
mediated. Furthermore, concentrations as low as 3 nM PGF2a could elicit a positive 
inotropic effect in atrial and single myocyte preparations (figures 5 & 11). As there 
are no specific FP receptor antagonists, structure-activity relationships using 
prostaglandins need to be compared for further evidence that the FP receptor is 
involved (Kennedy et al., 1982).
The higher potency of cloprostenol compared to PGF2a in perfused rat hearts is 
consonant to previous results obtained in bovine corpus luteum, where it is attributed 
to the higher binding affinity of cloprostenol for the FP receptor (Griffin et al., 
1997). The higher receptor affinity, in addition to cloprostenol’s stability, may also 
explain why the response to cloprostenol lasted longer than that of PGF2a (figures 1 
& 2).
FP receptor activation is associated with an increase in phosphoinositide metabolism. 
Otani et al. (1988) showed that the positive inotropic action of PGF2a correlated 
with accumulation of inositol phosphates in rat papillary muscles. If this correlation 
also occurs with cloprostenol in cardiac tissue, then the greater inotropic potency of 
cloprostenol suggests that even if the Ca2+ level is increased, this is not the sole 
mediator for the positive inotropy. This is deduced from the fact that while 
cloprostenol is more potent in accumulating inositol phosphates than PGF2a in Swiss 
3T3 fibroblasts, both show a similar ability for intracellular Ca2+ mobilisation in these 
cells (Griffin et al., 1997).
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4 .3  Effects of PGForv on mvocvte shortening and Ca2+ transients
Results from experiments with single myocytes in this thesis indicate that the role of 
Ca2+ is not important in mediating the contractile effects of PGF2a. PGF2a increased 
myocyte shortening and decreased diastolic length in a concentration dependent 
manner. The 40% increase in myocyte shortening and 6 % reduction in diastolic cell 
length in the presence of 3 pM PGF2a (figure 11) was not accompanied by significant 
changes in the Ca2+ transient amplitude nor in the diastolic Ca2+ level, as shown in the 
fura- 2  experiments (figure 19).
a) Possible experimental limitations
The lack of effect on the Ca2+ transients by PGF2(X was not due to compromised 
viability of the myocytes, as addition of noradrenaline to the myocytes at the end of 
the protocol could potentiate the amplitude of the Ca2+ transients (figure 20). In 
addition, noradrenaline shortened the duration of the Ca2+ transients, but PGF2a did 
not (figure 21). These effects of noradrenaline are consistent with its ability to 
activate the pi-adrenergic receptor, which is coupled to cAMP accumulation and 
protein kinase A stimulation.
Since fura-2 does buffer Ca2+ (Noble & Powell, 1990), there was a possibility that 
excessive buffering might have affected the outcome of the experiments. Therefore, 
myocyte shortening was monitored in parallel studies with myocytes loaded with the 
same concentration of fura-2 (5 pM). These myocytes showed a similar extent of 
increased shortening to PGF2a as in myocytes not loaded with fura-2 (figures 11 & 
14), implying that fura-2 buffering was not important.
Additionally, since PGF2(X caused intracellular alkalosis, changes in pHi also might 
have affected the binding of Ca2+ to fura-2, or affected the excitation spectra of fura- 
2, thus giving erroneous results when measuring Ca2+ transients. When they 
introduced fura-2 for Ca2+ measurement, Grynkiewicz and colleagues (1985) showed 
that changes in pH from 6.75 to 7.05, at a physiological Ca2+ concentration of 200 
nM, had little effect on fura-2 signals. In fact, there was a slight inhibition of Ca2+ 
binding to fura-2 by H+, indicating that any large rise in pHi would tend to increase
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the fura-2 fluorescence intensity. In contrast, Martinez-Zaguilan et al. (1991) 
reported that an increase in pH reduced the 340/380 fluorescence ratio of fura-2 for 
Ca2+, but they did their in vitro experiments without free Ca2+. Grynkiewicz also 
obtained similar results without free Ca2+. Regardless, Martinez-Zaguilan also 
concluded that the pH* effect on fura-2 is minor when pHi is more than 7.0. 
Therefore, it is unlikely that the change in pH of 0.08 units induced by PGF2(X would 
have affected the fura- 2  signals to a significant extent.
Lastly, the lack of effect of PGF2a on Ca2+ transients was not due to insufficient 
contact time of the drug with the myocytes. Fura-2 measurements were recorded 
only up to seven minutes, while the PGF2a-induced increase in myocyte shortening 
and alkalosis stabilised around ten minutes. However, this increase in shortening and 
alkalosis were statistically significant even at seven minutes, in contrast to the Ca2+ 
measurements. It would have been ideal to have measured Ca2+ transients for a 
longer period, but these experiments preceded that of the myocyte shortening 
experiments due to unavailability of equipment then. The time chosen for Ca2+ 
transient measurements was based on results from the whole hearts, where the 
PGF2a-induced increase in contractility was maximum within five to seven minutes at 
the highest dose (figure 1 ).
b) Effects of pHj on Ca2+ transients
The results from the fura-2 studies showing PGF2a's lack of effect on Ca2+ transients 
are not entirely unexpected. Other agonists that increase myocyte contractility such 
as phenylephrine, angiotensin II and endothelin-1 also show similar effects in some 
experiments (Gambassi et al., 1992; Terzic et al., 1992; Kohmoto et al., 1993; 
Ikenouchi et al., 1994), but show a slight increase in Ca2+ levels in other experiments 
(Fedida & Bouchard, 1992). These agonists and PGF2a have in common the fact that 
they activate the Gq-phospholipase C signalling pathway. In addition, phenylephrine, 
angiotensin II and endothelin-1 have also been shown to increase intracellular pH as 
part of their mechanisms of action (Kramer et al., 1991; Gambassi et al., 1992; 
Kohmoto et al., 1993).
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However, when the effects of pH changes alone are taken into account, the PGF2a- 
induced alkalosis would be expected to decrease Ca2+ transient amplitude. Allen and 
Orchard (1983) have shown that alkalosis induced by decreasing C 0 2 in the buffer 
decreases systolic Ca2+, as measured by aequorin light emission in rat papillary 
muscles. Consistent with this result in the reverse situation, acidosis increases Ca2+ 
transients (Allen & Orchard, 1983; Ward & Moffat, 1995). The fura-2 data 
presented in this thesis showed no significant change in Ca2+ transient amplitude with 
PGF2a, even though pH* was clearly increased in the BCECF experiments. This 
suggests that PGF2a or its second messengers may have direct actions that increase 
free intracellular Ca2+, and this would oppose the direct effect of the alkalosis. The 
apparent lack of effect of PGF2a on the Ca2+ transients may also be explained by its 
modulation of the balance between Ca2+ influx and Ca2+ extrusion.
c) Sarcoplasmic reticulum Ca2+ stores
Unlike some of the other prostaglandins, PGF2a does not activate cAMP in cardiac 
muscle (Metsa-Ketela, 1981; Otani et al., 1988), so this would rule out protein 
kinase A-induced Ca2+ fluxes. Instead, PGF2a activates the phosphoinositide cascade 
in rat hearts (Otani et al., 1988). This results in accumulation of IP3, which could 
potentially increase Ca2+ release from the sarcoplasmic reticulum, as it does in 
smooth muscle cells. However, Otani showed that this PGF2a-induced IP3 increase 
was transient (maximum at 30 s) and it did not correspond to the time course of the 
increase in contractility (up to 7 min). Additionally, localisation of the IP3 receptors 
in cardiac myocytes does not favour sarcoplasmic Ca2+ release. Kijima et al. (1993) 
showed that IP3 receptors were localised in the intercalated discs in rat atrial and 
ventricular myocytes, and there was little or no IP3 binding in the sarcoplasmic 
reticulum.
However, Otani et al. (1986) and Sabatini-Smith (1970) suggested that in guinea-pig 
hearts, the PGF2a-induced increase in contractility was dependent on increased Ca2+ 
release from the sarcoplasmic reticulum. Otani used procaine and TMB- 8  (10 jiM) 
as inhibitors of sarcoplasmic reticulum Ca2+ release, but these inhibitors do have 
additional effects. Procaine blocks sarcolemmal Na+ channels, while TMB- 8  inhibits
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Na+/Ca+ and Na+/H+ exchange at concentrations above 2 |iM in rat atria (Northover, 
1992), and inhibits sarcolemmal Ca2+, Na+ and K+ channels in guinea-pig ventricular 
myocytes at 10 |iM (Himmel & Ravens, 1996a,b). Therefore, these non-specific 
effects of TMB-8 render the results from Otani's study inconclusive. Sabatini-Smith 
(1970) did, however, find that PGF2a increased Ca2+ accumulation in the guinea-pig 
fragmented sarcoplasmic reticulum by measurements of 45Ca2+. This may be a direct 
stimulatory effect of PGF2a, in addition to the possible stimulation of sarcoplasmic 
reticulum Ca2+ loading by alkalosis in cardiac tissue (Fabiato & Fabiato, 1978; 
Orchard, 1987).
d) L-type Ca2+ current
A potential source of Ca2+ availability for the myofilaments is Ca2+ influx through L- 
type Ca2+ channels. Otani et al. (1988) reported that PGF2(X initiated contractions of 
25 mM K+ depolarised, electrically stimulated rat papillary muscles, and that this 
effect was blocked by the L-type Ca2+ channel inhibitor, nifedipine. The 
concentration of nifedipine used was 0.1 pM, a concentration that should not have 
unspecific effects. However, this experiment may not reflect the effect of PGF2ot at 
normal physiological K+ concentrations. This is because the initiation of muscle 
contractions, believed to be due to L-type Ca2+ channel activation, occurred over a 
time course clearly different to that of the positive inotropic action observed with 
normal K+ concentrations in the buffer. In addition, Otani et al. (1986) reported that 
the PGF2a-induced positive inotropy in guinea-pig atria was not inhibited by the Ca2+ 
channel antagonist, verapamil.
In rabbit ventricular myocytes, stimulation of the L-type Ca2+ current by angiotensin 
II is dependent on Na+-H+ exchanger activation (Kaibara et al., 1994). Since PGF2a 
stimulated the Na+-H+ exchanger in my study, PGF2a might be expected to increase 
intracellular Ca2+ by L-type Ca2+ channel activation. However, in our laboratory, 
Reeves showed that PGF2a did not affect the activity of L-type Ca2+ channels in patch 
clamp experiments in rat ventricular myocytes (figure 22). She used 100 nM PGF2a, 
a concentration that showed marked enhancement of myocyte shortening in this 
thesis.
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Metsa-Ketela (1981) has measured prostaglandin-induced 45Ca2+ accumulation in rat 
atrial preparations. In that study, prostaglandins F2a, E2, Ei, and I2 caused atria to 
accumulate 45Ca2+ similarly, but the increase in atrial contractility was highest with 
PGF2a. The lack of correlation between 45Ca2+ accumulation and contractility 
suggests that Ca2+ may not be important in mediating the positive inotropy of PGF2a. 
The concentration of PGF2ot used in the 45Ca2+ experiment described was 50 |iM, fifty 
times higher than the concentration required for maximal response in the same tissue 
preparation in my study. As PGF2ct is a lipid, this high concentration may have non­
specific effects on the cell membrane such as to increase its permeability and allow 
45Ca2+ entry into the cell.
e) Na+/Ca2+ exchange
Karmazyn et al. (1981) reported that PGF2a inhibited the Na+/K+ ATPase activity of 
rat sarcolemmal vesicles. This would result in increased intracellular Na+ and 
decreased gradient for Ca2+ expulsion through the Na+/Ca2+ exchanger. Therefore, 
Ca2+ would accumulate in the cell. It would seem likely that stimulation of the 
Na+/H+ exchanger by PGF2a seen in this thesis would also cause intracellular Na+ and 
Ca2+ to accumulate. However, Na+ loading (Rasmussen et al., 1989) and alkalosis 
(reviewed by Orchard & Kentish, 1990) also activate Na+ pumping of the Na+/Kf 
ATPase, as opposed to the direct inhibition of the ATPase by PGF2a as observed by 
Karmazyn. Any potential changes in the Na+ gradient may therefore be insufficient 
to activate Ca2+ influx through the Na+/Ca2+ exchanger. Additionally, the alkalosis 
induced by PGF2a may also stimulate Ca2+ efflux through this exchanger (Philipson et 
al., 1982; Dipolo &Beauge, 1982).
f) Ca2+ transient decay
In my study, the rate of decay of the Ca2+ transient was unchanged in the presence of 
PGF2oc (figure 21). Intracellular alkalosis should increase the rate of Ca2+ transient 
decay (Allen & Orchard, 1983) as an increase in the Ca2+ affinity of troponin C, 
coupled with sarcoplasmic reticulum Ca2+ pumping, should reduce free Ca2+ more 
quickly (Lee & Allen, 1996). If PGF2a did have other effects that increase free Ca2+ 
as discussed above, then this would explain why no change in the rate of decline was
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detected. Another hypothesis would be that the PGF2a-induced alkalosis did not 
increase the affinity of troponin C for Ca2+, instead it increased maximum Ca2+ 
activated force (discussed later in 4.8).
To summarise section 4.3, there is a possibility that PGF2a stimulates the 
sarcoplasmic reticulum Ca2+ loading, and inhibits the Na+/K+ ATPase, but the 
alkalosis per se induced by PGF2a offsets any potential Ca2+ increase, so that the Ca2+ 
transient amplitude appears unchanged.
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4.4 Effect of PG F^ on pH<
While the fura-2 experiments showed that PGF2(X did not change the Ca2+ transients, 
experiments using myocytes loaded with the pH indicator, BCECF, indicated that 
PGF2a clearly increased myocyte intracellular pH (figure 26). This alkalosis occurred 
over a time course similar to that of the increase in myocyte shortening and was 
reversible upon washout of the drug. This increase in pH of up to 0.08 units is 
comparable to that induced by other positive inotropic agents. Gambassi et al. 
(1992) recorded an increase of 0.06 pH units with phenylephrine in rat ventricular 
myocytes; Kramer et al. (1991) and Kohmoto et al. (1993) measured an increase of 
0.13 and 0.08 pH units with endothelin-1 in rat and rabbit ventricular myocytes 
respectively; while Ikenouchi et al. (1994) observed an increase of 0.2 pH units with 
angiotensin II in rabbit ventricular myocytes.
The PGF2a-induced intracellular alkalosis is likely to be due to activation of the 
Na+/H+ exchanger because the Na+/H+ exchanger inhibitor, HOE 694, abolished this 
alkalosis (figure 30). Loh et al. (1996) showed that HOE 694 was selective for 
NHE-1, the ubiquitous Na+/H+ exchanger isoform, over other sarcolemmal pH 
regulating mechanisms in guinea-pig myocytes. The concentration of HOE 694 used 
in my study was 10 |lM, close to the concentration of 30 (iM for maximal inhibition 
of the exchanger in guinea-pig myocytes. It did not affect basal intracellular pH with 
respect to time matched controls, consistent with the fact that the Na+/H+ exchanger 
is quiescent or minimally activated under basal conditions (Wallert & Frohlich, 
1989), and therefore ruling out physiological antagonism of the PGF2a-induced 
alkalosis. The control myocyte group did, however, show a gradual decline in pH* 
over the time course of the experiment. This effect has also been observed by Sun et 
al. (1996). As the PGF2a-induced pHi change of 0.08 units is the maximum 
difference compared to pre-drug value, this value is an underestimate when 
compared to time matched controls. When compared to time matched controls, 
PGF2a increased pHi by 0.13 units (figure 30).
Discussion - 1 2 0
4.5 The role of alkalosis in the positive inotropic effect of PGF^
Does the PGF2a-induced positive inotropic effect depend on the alkalosis? It appears 
that this is so, as HOE 694 also eliminated the increase in myocyte shortening at the 
same concentration that abolished the alkalosis.
HOE 694 itself, at a concentration of 10 jiM, sometimes increased basal myocyte 
shortening (figure 29). Scholz et al. (1993) also observed this HOE 694-induced 
contractile action in ischaemic rat working hearts. Therefore, to avoid complications 
in interpretation of the data, the effects of HOE 694 alone and in combination with 
PGF20C were always tested in the same myocyte. This basal effect of HOE 694 on 
myocyte shortening was not due to changes in pHi5 as checked in pH* experiments 
using BCECF loaded myocytes (figure 30). Other non-specific Na+/H+ exchanger 
inhibitors, such as amiloride, also inhibit the Na+/Ca2+ exchanger (Lazdunski et al., 
1985). Since HOE 694 has some structural similarity to amiloride, it may also have 
similar effects. However, results from Hendrikx et al. (1994) suggest that it is 
unlikely that 1 (iM HOE 694 inhibits the Na+/Ca2+ exchanger in isolated perfused rat 
hearts. In contrast, HOE 694 appears to inhibit Na+ channels (Legrand et al., 1996), 
but this would reduce basal myocyte shortening, and not increase it.
This increase in myocyte shortening with HOE 694 implies that the slight decline in 
shortening of 3% occurring in the presence of both PGF2a and HOE 694 is an 
underestimate of a negative inotropic effect uncovered when the PGF2ot-induced 
positive inotropy was removed. The actual figure under those conditions is about 
13% (figure 29). This PGF2a-induced negative inotropic effect is discussed further in 
section 4.8.
This thesis showed a correlation between the amplitude of the positive inotropic 
effect induced by PGF2ct and that induced by increasing stimulation frequency from 1 
Hz to 2 Hz (figure 16). Such evidence may also support the involvement of the 
Na+/H+ exchanger in the PGF2a-induced positive inotropy. The change in 
contractility with stimulation rate is known as a 'staircase' effect. An increased 
contractility, or positive staircase, is thought to be due to enhanced Ca2+ entry
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through L-type Ca2+ channels (Borzak et al., 1991) and the Na+/Ca2+ exchanger, and 
therefore increased sarcoplasmic reticulum Ca2+ loading (Frampton et al., 1991). 
Additionally, Na+ loading occurs during a positive staircase (Frampton et al., 1991).
More Na+ goes into the cell through Na+ channels during faster stimulation rates. 
Additionally, because of the concentration gradient across the sarcolemma, larger 
Na+ influx occurs in myocytes with lower cytosolic Na+ levels, rather than in those 
with higher Na+ levels. The enhanced depolarisation of the membrane then 
stimulates more Ca2+ influx through Ca2+ channels and Na+/Ca2+ exchange. This 
should result in a larger positive staircase in myocytes with lower cytosolic Na+. 
Similarly, if the PGF2ot-induced alkalosis is due to activation of the Na+/H+ exchanger, 
then the extent of alkalosis would also depend on the Na+ gradient across the 
sarcolemmal membrane, in the absence of intracellular Ca2+ changes. Therefore, the 
lower the cytosolic Na+ concentration, the higher the Na+ influx through the NaVfF 
exchanger, and the more protons extruded, the larger the resultant alkalosis and the 
PGF2a-induced positive inotropy.
The explanation for the correlation between the change in contractility induced by 
PGF2a and rapid pacing being dependent on Na+ loading is only hypothetical. 
However, this principle seems to apply to myocytes that show a negative staircase. 
In these myocytes, Na+ loading is less, and there is little change in cytosolic Ca2+, 
compared to myocytes displaying a positive staircase (Frampton et al., 1991). One 
example where this hypothesis could be extended is to hypertrophied guinea-pig left 
ventricular myocardium. This preparation does not show a positive staircase effect, 
and it has a characteristically higher intracellular Na+ content when compared to non- 
hypertrophied myocardium (Gray et al., 1997).
With 'normal' cells, the percentage of myocytes that showed a positive staircase in 
fifty randomly chosen myocytes in my study was 68%, while 8% showed a flat 
staircase, and 24% showed a negative staircase (decreased shortening). These values 
are similar to that found by Frampton et al. (1991). They reported that under similar
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conditions of room temperature and stimulation from 1 Hz, 60% of myocytes 
showed a positive staircase, while the others showed a flat or negative staircase.
The observation that there was correlation between the positive inotropy induced by 
PGF2a and that by rapid pacing was used towards the end of the project, to ensure 
that myocytes of the different protocol groups could potentially respond similarly to 
PGF2a. All myocytes used in the experiment testing the involvement of PKC in the 
PGF2a-induced increase in myocyte shortening were tested for their staircase effects 
early in the protocol. Myocytes were preselected so that the increase in shortening 
with rapid pacing was similar in both control myocyte group and in the group where 
the PKC antagonist, chelerythrine, was used (see 3.3.5c). The higher response to 
PGF2a in the control group shown in figure 33 when compared to that of figure 11A 
may be explained by this selection method, which is biased towards myocytes with a 
positive staircase.
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4.6 The role of PKC in the positive inotropic effect of PGFo»
Since it appeared that PGF2a stimulated the Na+/H+ exchanger and increased myocyte 
shortening, the role of PKC in these effects was investigated. It is questionable if 
PKC can phosphorylate the Na+/H+ exchanger in all types of myocytes. While rat 
NHE-1 contains phosphorylation sites for PKC (Kandasamy et al., 1995), rabbit 
cardiac NHE may not (Fliegel et al., 1992). This effect may be species dependent, as 
my study supports the idea that PKC does activate the Na+/H+ exchanger. The PKC 
inhibitor, chelerythrine, significantly attenuated both the PGF2a-induced alkalosis and 
positive inotropic effect (figures 34 & 35). The chelerythrine concentration used was 
2 pM, above the reported IC50 of 0.66 pM for PKC inhibition (Herbert et al., 1990). 
The specificity of this drug with regards to cardiac cellular mechanisms other than 
protein kinases is largely unknown, but chelerythrine has been reported to inhibit 
guinea-pig brain Na+/KfATPase at 100 pM (Cohen et al., 1978). If this also occurs 
in cardiac myocytes, then high concentrations of chelerythrine would cause Ca2+ 
accumulation and increase myocyte contractility. Indeed, higher concentrations 
above 2 pM could not be used as chelerythrine was found to consistently increase 
basal contractility in a concentration dependent manner (figure 32).
In view of the possible lack of specificity of chelerythrine, whether PKC is solely 
responsible for the PGF2a-induced activation of the Na+/H+ exchanger cannot be 
concluded. The Na+/H+ exchanger is also regulated by Ca2+-calmodulin dependent 
protein kinase (Fliegel et al., 1992; Le Prigent et al., 1997), members of the MAP 
kinase family and those activated by extracellular signal-regulated (ERK) kinases 
(Takahashi et al., 1997), or by a closely associated regulator protein (Noel & 
Pouyssegur, 1995). Since PGF2ot did not change Ca2+ transients in this thesis, it is 
unlikely that Ca2+-calmodulin dependent protein kinase activated the Na+/H+ 
exchanger. Other than the phospholipase C pathway, PGF2a activates tyrosine kinase 
and MAPK cascade in NIH-3T3 cells (Watanabe et al., 1994; Watanabe et al., 
1995), suggesting that the Na+/H+ exchanger may be activated by member(s) of the 
MAPK cascade. In vascular smooth muscle cells, angiotensin II activates a 90 kDa 
protein termed p90rsk, which phosphorylates NHE-1 and is dependent on ERK1/2 
kinase (Takahashi et al., 1997). Also, although activation of the MAPK cascade may
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be more important for cell proliferation, there is a possibility that it can regulate 
contraction. The PGF2a-induced rat puerperal uterine contraction depends partly on 
Ca2+ mobilisation and partly on MAPK kinase activity (Ohmichi et al., 1997). 
Inhibition of MAPK kinase with PD098059 attenuates the PGF2a-induced uterine 
contraction without affecting Ca2+ mobilisation. So, perhaps PGF2tx also depends on 
MAPK kinase or some other kinase, in addition to PKC, to activate the Na+/H+ 
exchanger.
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4.7 Effects of alkalosis on the contractile proteins
As discussed, the positive inotropic effect induced by PGF2a is probably not due to 
an increase in intracellular Ca2+, but is associated with an increase in intracellular pH. 
Fabiato & Fabiato (1978) showed that alkalosis increased the affinity of troponin C 
for Ca2+, and it also increased the maximum Ca2+ activated force of skinned rat 
papillary muscles. Such effects on myofilament Ca2+ sensitivity could account for the 
positive inotropy of PGF201. It would also explain the PGF2tt-induced reduction in 
myocyte diastolic length in the absence of changes in diastolic Ca2+ (Spurgeon et al.,
1992). One example in which PGF2(x has been shown to sensitise the myofilaments to 
Ca2+ is vascular smooth muscle (Suematsu et al., 1991, Hori et al., 1993).
For further evidence that PGF2a sensitises the cardiac myofilaments to Ca2+, I plotted 
a phase-plane diagram according to Spurgeon et al. (1992). PGF2a shifted the late 
relaxation phase of the fura-2/myocyte length loop upward and leftward of the 
control loop, indicating an enhanced myofilament sensitivity to Ca2+ (figure 23). This 
method, however, suffers from drawbacks in my study because the average myocyte 
length and fura-2 fluorescence were obtained from separate experiments. 
Furthermore, the synchronisation of the twitch and Ca2+ could not be accurately 
defined.
However, abolishing the PGF2a-induced alkalosis with HOE 694 did abolish the 
increase in myocyte shortening. This means that the positive inotropic effect was 
most probably due to the alkalosis, as the only established means by which this could 
occur without Ca2+ changes was by increasing the affinity of troponin C for Ca2+ and 
by increasing the maximum Ca2+ activated force.
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4.8 PGF?rr -induced negative inotropic action
Brenner et al. (1987) reported that concentrations of 1 |iM to 100 jxM PGF2(X 
reduced the contractility of cultured neonatal rat ventricular myocytes. The 
possibility that PGF2a may also have a negative inotropic effect in adult ventricular 
myocytes is deduced from observations during the course of the experiments. 
Firstly, when the increase in myocyte shortening induced by PGF2a was inhibited by 
HOE 694, a reduction in myocyte shortening was observed (figures 28C & 29). 
Secondly, single ventricular myocytes occasionally showed an initial transient 
reduction in shortening before the positive inotropic effect of PGF2ct developed 
(figures 28A & 33A).
The depressant action of PGF2a may be due to selective activation of PKC isozymes. 
PKC5 and PKCe phosphorylation of troponin I decreases the activity of 
actinomyosin MgATPase, and may desensitise the cardiac filaments to Ca2+ (Noland 
& Kuo, 1991; Jideama et al., 1996). On the other hand, PKC may reduce cardiac 
contractility by reducing Ca2+ transients (Capogrossi et al., 1990). Kissling et al. 
(1997) reported an example of receptor mediated negative inotropy where PKC 
could have been involved. In their study, activation of the a-adrenergic receptor by 
low doses of adrenaline reduced the contractility of rat papillary muscles; this effect 
was abolished by staurosporine.
This dual inotropic effect of PGF2a may explain why PGF2a prolonged the 
contraction-relaxation cycle in the atria, but not in ventricular myocytes (figures 8 & 
13). An increase in pHi under steady-state conditions should prolong the duration of 
the contraction-relaxation cycle as the affinity of troponin C for Ca2+ is increased 
(Allen & Orchard, 1983). However, the negative inotropic effect of PGF2a seen in 
ventricular myocytes but not in atria, may oppose part of the action of the alkalosis. 
The result would be that the time for relaxation appeared unchanged. If this is true, 
then, the net effect of the PGF2a-induced alkalosis in ventricular myocytes would be 
to increase maximum Ca2+ activated force.
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4.9 Coronary effects of PGF^
Besides modulating cardiac contractility, PGF2a also modulates coronary tone. 
PGF2a transiently increased and then decreased coronary perfusion pressure in 
Langendorff perfused rat hearts (figures 1 & 3).
The transient increase in perfusion pressure implies that PGF2a constricted resistance 
coronary vessels. The mechanism of this effect was not studied, but it may be 
mediated partly by sensitisation of the myofilaments to Ca2+ (Hori et al., 1993; 
Suematsu et al., 1991), and also by IP3-induced sarcoplasmic reticulum Ca2+ release 
(Morimoto et al., 1990a/b; Kurata et al., 1993). This PGF2a-induced 
vasoconstriction may be mediated by TP receptors, as shown in rat aorta (Rapoport,
1993), human hand veins (Amer et al., 1991) and cat coronary arteries (Nakajima et 
a l , 1990).
The prolonged vasodilation induced by PGF2a coincided with the sustained positive 
inotropic response. This vasodilation may either be metabolically induced, or directly 
FP receptor mediated. The increased workload and 0 2 demand due to the positive 
inotropic effect could induce the generation of vasodilator metabolites such as 
adenosine or prostacyclin (Feigl, 1983). In fact, De Deckere and associates (1979) 
have detected the release of the vasodilator prostaglandins, prostaglandins E2 and 
prostacyclin, in the perfusate of isolated rat hearts treated with PGF2a. On the other 
hand, PGF2a may have additional vasodilator actions. PGF2a mediated vasodilation 
occurs in human hand veins (Amer et a l, 1991), and in rabbit jugular veins where 
nitric oxide is implicated (Chen et al., 1995). Although atrial natriuretic factor is 
released by PGF2a in perfused rat hearts, it does not appear to contribute to the 
vasodilation (Rayner et al., 1993).
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4.10 Potential regulatory roles of PGFo„
The results from this study may explain some of PGF2o's other cardiac effects seen in 
different experiments.
Cardiac release of PGF2a increases in some pathological situations. Human hearts 
made temporarily ischaemic by rapid pacing are associated with almost a three-fold 
increase of PGF2o( in the coronary sinus blood (Berger et al., 1977). Rat hearts with 
infarction and hypertrophy have six-fold more extractable PGF2(S than control hearts 
(Lai et al., 1996). Also, left ventricle samples taken from rabbits that have been 
subjected to acute pressure overload show up to ten times basal levels of PGF2a 
(Chazov et al., 1979). The significance of these observations is not clear.
Since PGF2a increases the contractility of ischaemic rat hearts (Karmazyn, 1993), its 
myofilament Ca2+ sensitising action may be beneficial, as opposed to increasing 
cytosolic Ca2+. Firstly, energy for extruding excess Ca2+ through the Ca2+ ATPases is 
not wasted, and secondly, this mode of action would not promote Ca2+ overload in 
the energy deprived, arrhythmia prone, ischaemic heart. However, Karmazyn (1986) 
reported that PGF2a was detrimental to recovery upon reperfusion of low-flow 
ischaemic rat hearts. The amount of PGF2a in the coronary effluent also doubled 
under these conditions. The release of PGF2a may be stimulated by platelet 
activating factor (Rayner, 1993) and oxygen free radicals (Gupte et al., 1996), which 
contribute towards development of reperfusion injury. Excessive stimulation of the 
Na+/H+ exchanger, which is already active upon reperfusion of ischaemic hearts, is 
known to indirectly induce Ca2+ overload by perturbation of the Na+/Ca2+ exchanger 
(Lazdunski et al., 1985, Tani, 1990). Such an action may contribute to the PGF2a- 
induced ventricular failure observed by Karmazyn (1986).
From another point of view, PGF2(X may potentially be beneficial in pathological 
situations because it could mimic ischaemic preconditioning. Preconditioning is a 
phenomenon whereby a brief period of ischaemia and reperfusion protects the heart 
against subsequent prolonged ischaemic insult. PKC is believed to be a mediator of 
this event (Ytrehus et al., 1994; Brooks & Hearse, 1996). Therefore, since PGF2a
Discussion - 1 2 9
did activate PKC in my study, it may potentially be protective, as other PKC 
activators such as bradykinin, angiotensin II and endothelin-1 do mimic ischaemic 
preconditioning (Liu et al., 1995, Wang et al., 1996).
PGF2a also releases atrial natriuretic factor (ANF) from rat heart and myocytes 
(Rayner et al., 1993; Lai et al., 1996). This would be beneficial in failing hearts 
because ANF causes peripheral vasodilation and reduces blood volume, ultimately 
reducing cardiac afterload. Since PGF2a activates the Na+/H+ exchanger, this may 
play a part in the release of atrial natriuretic factor and the ventricular hypertrophy 
seen by Adams et al. (1996) and Lai et al. (1996) in neonatal rat cells. Activation of 
the Na+/H+ exchanger is associated, but not required, to initiate cell growth and 
proliferation (Noel & Pouyssegur, 1995). Although cardiac hypertrophy enables the 
heart to adapt to demands for increased cardiac output or injury in the short term, 
excessive hypertrophy is detrimental.
High concentrations of PGF2a reduce the maximum rate of depolarisation in guinea- 
pig atria, rat papillary muscle and cultured chick heart cells (Forster et al., 1974; 
January & Schottelius, 1974; Kecskemeti et al., 1978). This may be due to reduced 
Na+ influx through Na+ channels, as Na+/H+ activation reduces the sarcolemmal Na+ 
gradient. This indirect Na+ channel inhibitory effect may explain the antiarrhythmic 
action of high concentrations of PGF2a (Forster et al., 1973; Vapaatalo et al., 1978).
In summary, the release of PGF2a under pathological conditions appears to be 
protective in some cases, but is detrimental in others.
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4.11 Conclusion
In conclusion, PGF2a appears to activate the Na+/H+ exchanger, at least partly by 
PKC phosphorylation. The resultant alkalosis sensitises the contractile filaments to 
Ca2+, in the absence of overall changes in Ca2+ transients, and this results in the 
PGF2a-induced positive inotropic action in rat ventricular myocytes.
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